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CHAPTER 1 
INTRODUCTION 
Arboviruses (arthropod-borne viruses) are viruses that are maintained in nature through 
transmission between susceptible vertebrate hosts by haematophagous arthropods. These viruses 
multiply and produce viraemia in the vertebrates, replicate In the tissue of arthropods, and are then 
passed on to new vertebrates by the bites of these arthropods (Simpson, 1984). 
There are 504 arboviruses registered in the International Catalogue of Arboviruses (Labuda, 1991) 
of which approximately 100 are capable of infecting man. The majority of arboviruses have been 
serologically classified in the families; Togaviridae, Flaviviridae, Reoviridae, Bunyaviridae, and 
Rhabdoviridae. 
Mosquitoes are the most important arbovirus vectors, followed by ticks. Phlebotomines, 
Culicoides species and Cimex species are also involved in the transmission of some arboviruses 
(Simpson, 1984). 
Studies have shown that Sindbis (SIN), West Nile (WN), Rift Valley fever (RVF) and Wesselsbron 
(WSL) viruses are the most prevalent arboviruses in the Orange Free State (Mcintosh, 1980) and 
with generalised clinical symptoms such as fever, headache, general malaise, muscle or jOint pains 
and a macular or maculopapular rash (Lennette & Schmidt, 1979) a conclusive diagnosis for 
arbovirus infections can only be made by the laboratory. 
Standard tests for identifying viruses or detecting viral antibodies are often time consuming, 
expensive and necessitate sophistication. No commercial diagnostic kits are available for detecting 
antibodies to certain arbovlruses, therefore, it was necessary to develop a simple, cost-effective 
test for screening and determining specific antibodies of the immunoglobulin G (lgG) and 
Immunoglobulin M (lgM) class against RVF, SIN, WN and WSL viruses. 
In the conventional enzyme-linked immunosorbent assays (ELISA) for detecting viral antigens and 
antibodies, polystyrene or other materials (which have a rather low binding capacity for proteins) 
are generally used as the solid phase. On the other hand, the superior binding capacity of 
nitrocellulose (NC) for the adsorption of proteins from a polyacrylamide gel following 
electrophoresis by the Western blot technique, has been demonstrated and implicated the 
advantageous use of NC instead of polystyrene as the solid phase (Towbin et al. 1979). 
1 
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The aim of this study was to develop a dot-ELISA by using a NC membrane as solid phase on 
which to spot antigens for later visualisation of antigen-antibody complexes of RVF, SIN, WN and 
WSL with enzyme-conjugated anti-human immunoglobulins of the IgG, as well as the IgM class, 
using a substrate which gives an insoluble colour reaction. 
2 
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CHAPTER 2 
LITERATURE REVIEW 
2.1. RIFT VALLEY FEVER VIRUS 
2.1 .1. CLASSIFICATION 
RVF virus is a member of the genus Phlebovirus of the family Bunyaviridae. For many years after 
its isolation, RVF virus was an unclassified arbovirus. It was demonstrated by Murphy et al. (1973) 
that RVF virus was morphologically similar to the bunyaviruses and tts classification, as a member 
of the family Bunyaviridae, was confirmed by basic molecular studies (Rice et al., 1980). 
Serological tests indicated that RVF virus was antigenically related b the phlebotomus fever 
viruses and therefore belonged to the Phlebovirus genus (Shope et al., 1980). 
2.1.2. EPIDEMIOLOGY 
2.1.2.1. GEOGRAPHICAL DISTRIBUTION 
According to Daubney et a/. (1931) RVF was first recognised in the Rift Valley of Kenya in 1930 
where tt primarily affected sheep, causing an increased abortion rate in pregnant ewes and 
mortaltty among lambs. Fatal disease occurred predominantly in young sheep, cattle and goats, 
manifesting wtth focal liver necrosis. Human infection resulted in a mild febrile illness. The illness 
was thought to be probably caused by an arthropod-borne virus. It appeared, retrospectively, that 
the disease had been present for about 20 years in the area of the Great Rift Valley in Kenya. 
Major epizootics of RVF occurred in Kenya in 1931 and 1978, South Africa in 1951 and 1975, 
Namibia in 1955 and 1974, Zimbabwe in 1957, 1969 and 1978, Sudan in 1973, Zambia in 1973 and 
1978, and Egypt in 1977. Limtted outbreaks were also reported from Kenya, Mozambique, South 
Africa, Sudan, Tanzania and Uganda. Serological evidence confirmed that the virus was present in 
numerous sub-Saharan African countries (Meegan & Bailey, 1989). The first confirmed outbreak in 
West Africa occurred in Maurttania in 1987 (Ksiazek et a/., 1989), and the first fatal case of RVF in 
Madagascar was reported by Morvan et a/. (1992). 
During the summer of 1950 to 1951 the first known epizootic of RVF occurred in South Africa 
(Alexander & Dickson, 1951; Mundel & Gear, 1951). This epizootic mainly involved areas of the 
western and south-western Orange Free State and the north-western Cape Province (Kimberley 
area), with isolated outbreaks occurring in the western and southern areas of the Transvaal (Gear 
eta/., 1951). 
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According to Weiss (1957), several laboratory workers contracted the disease, 20 000 humans 
were Infected and over 100 000 sheep and cattle died during this outbreak. Serological evidence of 
RVF virus infection was also found in a number of herds of cattle in the Knysna district of the 
southern Cape Province. 
RVF re-appearecl in South Africa in the late autumn of 1953 In epizootic form in an area near 
Luckhoff in the Orange Free State (Van der Linde, 1953). 
During April , 1955, an outbreak of RVF occurred on farms in the Marienthal district, Namibia, and in 
the late summer of 1956 an epizootic of RVF was reported from farms in the Kroonstad district in 
the Orange Free State (Weiss, 1957). 
After an apparent absence of 13 years, RVF re-appeared in the summer of 1968 and 1959 in a 
widespread epizootic in Zimbabwe wtth smaller outbreaks in the coastal lowlands of Natal, South 
Africa and Mozambique, involving only cattle. Further outbreaks occurred during 1970 in several 
districts of the Orange Free State and south-eastern Transvaal (Mcintosh, 1972). 
After exceptionally heavy rains over the Karroo and the western region of the Cape Province in 
1974 and 1975, an epizootic of RVF occurred in the sheep and cattle-farming districts, causing the 
loss of many thousands of livestock. Associated wtth this epizootic many cases of human 
Infections were reported, and for the first time ever, human deaths due to haemorrhagic 
complications of RVF were recognised (Van Velden et al., 1977). Later in the 1977 to 1978 Egyptian 
epidemic, extensive human involvement, wtth fatal tty estimates of up to 600 persons dying of 
haemorrhagic fever associated wtth acute hepatttis was reported (Shope et al., 1982) . 
Epidemiological studies in South Africa revealed an extensive epizootic area for RVF. It includes 
the Karroo, the Cape Province north of the Orange River, the southern half of Namibia, the Orange 
Free State Province, and the southern half of the Transvaal Province, excluding the eastern 
Lowveld region of that province. In the coastal lowlands of Natal, cattle are enzootically infected 
wtth RVF virus, wtth a minimal infection rate in humans (Mcintosh & Jupp, 1981). 
2.1.2.2. VECTORS AND HOSTS 
Numerous species of haematophagous arthropods are incriminated as possible vectors of RVF 
virus. These incriminations are based on the isolation of virus from these species during or 
following peak periods of transmission. Different species of mosquttoes were suggested to be 
involved as vectors or reservoirs in the various geographic areas of Africa where the disease is 
4 
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endemic (Table 1) (Meegan & Bailey, 1989). Meegan et al. (1980) also implicated a Rhipicephalus 
tick as a vector or host for RVF virus. 
TABLE 1. ARTHROPODS FOUND NATURALLY INFECTED WITH RVF VIRUS 
Species 
Aedes 
8edimorphus 
cumminsii 
dalzieli 
dentatus 
tarsalis 
durbanensis 
Neomelaniconion 
circumluteo/us 
lineatopennis 
paJpalis 
Ochlerotatus 
caba/Jus 
juppi 
Stegomyia 
africanus 
dendrophilus 
furcifer 
Anopheles 
Anopheles 
coustani 
Culex 
coustani and fusicolor 
Cellia 
pauliani and squamosus 
christyi 
pharoensis 
antennatus 
antennatus and annuJioris gpo 
simpsoni and vansomereni 
antennatus, simpsoni and vansomereni 
theiferi 
zombaensis 
Eume/anomyia 
rubinotus 
£retmapodites 
quinquevittatus spp. 
CoquiJleftidia 
fuscopennata 
grandidieri 
Mansonia 
uniformis 
Mansonioides 
africana 
uniformis 
Other Diptera 
(Meegan & Bailey, 1989) 
Culicoides spp. 
Simulium 
locality 
Burkina Faso 
Kenya, Senegal 
Zimbabwe 
Uganda 
Kenya 
Uganda, South Africa 
Zimbabwe, South Africa, Kenya 
Central African Republic 
South Africa 
South Africa 
Uganda 
Uganda 
Burkina Faso 
Zimbabwe 
Madagascar 
Madagascar 
Kenya 
Kenya 
Kenya,Nigeria 
Madagascar 
Madagascar 
Kenya, Madagascar, 
Kenya, South Africa, Zimbabwe 
Kenya 
Kenya 
South Africa, Uganda 
Uganda 
Madagascar 
Madagascar 
Uganda, Central African Republic 
Uganda 
Nigeria 
South Africa 
RVF epizootics occurred following unusually heavy rainfall and the presence of large numbers of 
mosquitoes, giving merit to the hypothesis that the virus may be transmitted and maintained 
transovarially in floodwater mosquitoes. Linthicum et al. (1985) recovered RVF virus from both 
male and female Aedes lineatopennis reared in the laboratory, supporting the hypothesis that 
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transovarial transmission Is the most likely mechanism for maintaining the virus during 
environmental conditions that are unsuitable for active transmission between vector and 
susceptible vertebrate hosts. 
In South Africa Gear et a/. (1955) Isolated RVF virus from 6 pools of Ae. cabal/us and 3 pools of 
Culex theileri during the 1953 outbreak. It was also shown that RVF could be transmit1ed by 
naturally infected Ae. cabal/us. 
In 1956. RVF virus was again Isolated from Cx. theileri during an outbreak of disease among sheep 
in the Wesselsbron district. Orange Free State. according to unpublished data of the Arbovirus 
Research Unit (Mcintosh. 1972). 
The isolation of RVF virus during field investigations implicated Cx. theileri as the main vector in 
Zimbabwe. as well as in the Kroonstad and Johannesburg districts of South Africa during the 1969 
epizootic. Ae. lineatopennis was also suggested to playa role as vector In Zimbabwe. while Ae. 
circumluteo/us was mentioned as a possible vector in the northern parts of Natal (Mcintosh. 1972). 
During an outbreak of RVF in the coastal region of Natal in 1981. RVF virus was isolated from both 
Cx. zombaensis and Cx. neavei. Laboratory tests revealed that Cx. zombaensis was the main 
vector during this outbreak and that Ae. circum/uteolus was possibly a vector during the earlier 
stages (Mcintosh et al .• 1983). 
In experimental studies Mcintosh et a/. (1980(a)) demonstrated that Cx. theileri, Cx. univittatus, Ae. 
juppi and Ae. lineatopennis (plateau fauna). Ae. aegypti, Eretmapodites quinquevittatus, Cx. 
zombaensis and Cx. neavei (Natal coast) and Cx. quinquefaciatus (both regions) . can transmit 
RVF virus, although some of these species are not efficient vectors. It was evident that Cx. theileri 
was very capable of transmit1ing virus to sheep and cattle. therefore acting as the main vector on 
the inland plateau. 
Numerous studies have been conducted to determine the role of vertebrate hosts in the natural 
cycle of RVF virus (Smithburn et al .• l948; Davies & Onyango. 1978; Davies & Addy, 1979; 
Hoogstraal et al .• 1979; Davies & Unthicum. 1986). Although the possible role of wild rodents has 
been investigated, results have shown that they are probably not involved as amplUication hosts of 
the virus (Weinbren & Mason. 1957; Davies. 1975; Swanepoel et al., 1978). However. Weinbren & 
Mason (1957) suggested that the field rat Arvicanthis abyssinicus nubilans can fulfil all the 
requirements necessary to act as a natural host. Swanepoel et al. (1978) have shown that four 
species of murids (Rodentia: Muridae) were capable of circulating amounts of RVF virus likely to 
6 
© Central University of Technology, Free State
be infective for mosquitoes. Pretorius (1992) reported on viraemia studies performed on Aethomys 
namaquensis (Rodentia: Muridae) and concluded that this species can act as asymptomatic 
carriers of RVF virus in nature. 
2.1.3. DISEASE ASSOCIATIONS 
2.1.3.1. ANIMALS 
Disease in Africa appears to be limited to domestic animals and outbreaks are most obvious in 
sheep and cattle, and are characterised by widespread abortion in pregnant animals and a high 
fatality rate in neonates (Daubney et al., 1931; Alexander & Dickson, 1951). 
The severity and progression of the disease is inversely proportional to age, and lambs, calves, 
and kids are most susceptible to RVF (Meegan & Bailey, 1989). 
According to Dickson (Alexander & Dickson, 1951) the clinical symptoms of RVF can be classified 
In 4 stages: 
The peracute form 
This form is common in lambs. The incubation period is about 12 h and death follows within 36 h 
as a result of liver necrosis. The mortality rate varies between 95 and 100 %. 
The acute form 
This form can occur in lambs and to a lesser extent in adult sheep. The symptoms appear 
suddenly with a rapid rise in temperature, vomiturition, a mucopurulent discharge from the nose, 
rapid pulse, unsteady gait, and abortion in ewes. Death usually takes place 24 to 48 h after the 
onset of symptoms. The mortality rate can vary from 20 to 30 %. 
The sub-acute form 
This form is common in adult sheep and cattle. A temperature rise, lasting from 24 to 96 h, can be 
detected. Inappetence and general weakness are present. In pregnant animals abortion may be 
the only symptom. Milk production decreases rapidly. The mortality rate is low and in cattle it can 
be less than 10 %. 
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The mild or inapparent form 
This form usually occurs in adult sheep and cattle. There is only a slight febrile reaction and the 
disease can only be diagnosed serologically. 
Swine, horses, domestic buffaloes and camels do not become ill, although abortions due to RVF 
have been reported in camels and buffaloes. Inoculation studies in wild rodents revealed a brief, 
lOW-level viraemia, with development of protective antibodies. Both wild and domestic fowls 
appeared refractory to infection (Meegan & Bailey, 1989). 
In susceptible animals, the liver is the primary site of viral replication and on post-mortem it oiten 
appears a light brown-yellowish colour. Small white spots of necrotic tiss\Je, surrounded by small 
haemorrhages under the capsule, can be seen. The liver becomes congested, haemorrhagic and 
soit. The kidneys can display congestion of the cortical and medullary blood vessels. The digestive 
tract can be affected and in acute cases a severe haemorrhagic gastro-enteritis can be present 
(Alexander & Dickson, 1951). 
2.1.3.2. HUMANS 
During an outbreak, disease usually appears first in livestock, while humans are secondarily 
infected (Meegan, 1979; Mcintosh et a/., 1980(a)). RVF infection occurs mainly in farmers and 
others who come in close contact with animals infected with the disease (Daubney et al., 1931; 
Mundel & Gear, 1951; van Velden et al., 1976). 
The virus can be transmitted by contact with tissue or blood of infected animals during care, 
autopsy, slaughter or disposal of infected carcases (Chambers & Swanepoel, 1980). Infection is 
postulated to result from transcutaneous or aerosol exposure (Hoogstraal et al., 1979). During an 
epizootic, when there are many infected and dying animals, contact transmission may be a more 
important source of human infection than mosquito transmission (Joubert et al., 1951). Laboratory-
acquired infections, probably due to aerosols, have long been recognised and extreme 
precautions should be taken by those working with the virus (Sabin & Blumberg, 1947). 
2.1.4. DIAGNOSIS 
2.1.4.1. CLINICAL 
RVF in man was considered to be an influenza-like disease from knowledge obtained from 
laboratory infections (Daubney et al., 1931). Recovery from infection was usually complete. Schrire 
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(1951) described the loss of central vision in a few patients thought to be caused by RVF during an 
epizootic in South Africa In 1950. The first fatal~ies due to RVF were described by van Velden et al. 
(1977) during the 1975 epizootic in South Africa. Several patients were diagnosed w~h 
encephalitis. Five patients developed a haemorrhagic state with profuse bleeding and died soon 
after admission to hospital. A further 2 patients died from encephal~is. 
It was only during the 1977 outbreak of RVF in Egypt that the full potential of RVF virus as a severe 
human pathogen was recognised. Four different forms of disease were recognised (Meegan et al., 
1981). 
Uncomplicated RVF 
Patients experienced the sudden onset of malaise and fever with an in~ial rigor, severe headache, 
'backbreaking' myalgia and anorexia. Some experienced nausea and vom~ing. On examination 
they were acutely ill and toxic, mostly w~h temperatures above 39 'C, with flushed faces and 
suffused conjunctivae. The febrile period lasted 4 to 7 days and a second temperature rise was 
observed during this period in a minority of cases. Patients improved symptomatically over the 
next 4 to 7 days and recovered completely w~hin 2 weeks (Abdel-Wahab et al., 1978). 
RVF with ocular complications 
Patients experienced the sudden onset of an acute febrile illness followed by a decrease in visual 
acu~y w~hin 5 to 15 days. The most common clinical findings were macular, paramacular or 
extramacular retinal lesions which frequently occurred bilaterally. Oedema, haemorrhage and 
vascul~is were observed. Patients w~h more severe macular lesions had permanent loss of central 
vision (Siam et al., 1980). 
RVF with meningoencephalitis 
Patients described the acute onset of a febrile illness followed in 5 to 15 days by neurological 
symptoms which included disorientation, hallucination and vertigo. All exhibited meningismus. 
Hemiparesis and decerebrate posturing was noted in some cases. The cerebrospinal fluid showed 
cell counts of 20 to 600 cells/mm3, mainly lymphocytes, but glucose and protein concentrations 
were normal. Recovery was slow and hemiparesis continued to manifest in some patients for up to 
3 months (laughlin et al., 1979). 
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RVF with haemorrhage and jaundice 
Patients experienced the sudden onset of a febrile illness, but 2 to 4 days later developed jaundice 
and haemorrhagic manifestations. Haematemesis, melaena, gingival bleeding and petechial and 
purpuric skin lesions were common. In fatal cases, death occurred within a week after the onset of 
jaundice. Shock and hepatic insufficiency were suspected as the cause of death. Virus was 
isolated from sera during both the febrile phase and the afebrile period which accompanied the 
onset of haemorrhagic signs. Patients with haemorrhages either died 3 to 6 days later or slowly 
convalesced and recovered completely (Laughlin et a/., 1979; Meegan, 1979). 
RVF virus is highly abortive in many animals, and perhaps in humans. However, during the 
Egyptian epidemic, this possibility could not definitively be resolved (Abdel-Aziz et a/., 1980). 
2.1.4.2. LABORATORY 
The virus circulates to a high titer in sheep and cattle and virus isolation is diagnostic of RVF virus 
infection. Whole blood or serum collected at the peak of pyrexia, specimens of liver tissue, 
placenta and fetus transported on wet ice, have been the most common samples used for virus 
isolation (Van Velden et a/., 1977; Mcintosh et a/., 1980(b); Meegan & Bailey, 1989). RVF virus was 
also isolated from faecal specimens and throat washings from patients during the Egyptian 
epizootic (Imam et a/., 1979). 
The virus can be isolated in a number of cell culture systems, including Vero (African green 
monkey kidney cell line), BHK-21 (baby hamster kidney cell line), and many primary cell cultures 
(Weiss, 1957). In cell cultures, the virus has grown to titers of 1 to 5 X 107 pfujml and produced 
complete cytopathic effect (CPE) within 3 to 5 days. The virus has grown to similar titers in 
mosquito cell cultures, but produced no CPE (Peters & Anderson, 1981; Oelofsen et a/., 1990). 
Susceptible laboratory animals for virus isolation are suckling mice, adult mice, hamsters and 1 to 
3 day old lambs. Isolation attempts should always include adult white mice and hamsters because 
RVF virus is one of the few viruses that will kill adult mice and hamsters within 1 to 4 days after 
inoculation by the intraperitoneal (Lp.) route. Histopathological examinations will reveal 
characteristic liver necrosis in all susceptible animals (Daubney et a/., 1931; Sabin & Blumberg, 
1947; Smithburn et a/., 1948; Gear et a/., 1951; Alexander & Dickson, 1951). 
Viral isolates can be identified as RVF by the plaque reduction neutralising test (PRNT) using 
reference anti-RVF virus polyclonal or monoclonal antiserum (Shope et a/., 1982). 
10 
© Central University of Technology, Free State
Rapid diagnostic methods to demonstrate viral antigen In specimens have been used. Gel diffusion 
has demonstrated antigen In specimens, but the test is not sens~ive. Immune electron microscopy, 
immunofluorescence (IF) and radio-immunoassay (RIA) tests utilising reference antibodies have 
proved to be successful for detecting antigen in specimens (Meegan & Bailey, 1989). 
Niklasson et ai. (1983) developed a double-antibody ELISA to detect RVF virus antigen in 
specimens. This test is suitable for field evaluations since it proved to give a rapid, specific and 
sens~ive result in diagnostically relevant concentrations. Furthermore, this test can be prepared, 
standardised and performed w~h inactivated virus, increasing ~s util~y in surveillance in non-
endemic areas. 
The following serological tests have been commonly used to demonstrate RVF virus antibody in 
domestic animals and humans: complement fixation (CF), agar gel diffusion, haemagglutination-
inhiMion (HI), mouse neutralisation, PRNT, IF and ELISA. In some of these tests, various low-titer, 
nonspecific cross-reactions do occur between RVF antigen and antibodies developed in response 
to infection w~h other viruses in the phlebotomus fever serogroup (Tesh et ai., 1982). 
A seroconversion, or a high convalescent anti-RVF virus antibody mer obtained by serological 
tests, provides strong evidence of RVF infection. The detection of IgM antibodies in human sera is 
important for the early diagnosis of RVF infection, and the development of an ELISA IgM test could 
become an important tool in the future (Niklasson et ai., 1984; Soliman et ai., 1988). 
2.1.5. PREVENTION AND CONTROL 
Immunisation of susceptible animals Is the most effective means of control of RVF. Two types of 
vaccine are currently used to immunise sheep and cattle (Shope et ai., 1982). 
The attenuated live virus vaccine (Smithburn strain) is highly effective, but causes a small 
percentage of pregnant sheep to abort after immunisation. It is relatively inexpensive and has been 
extensively used in endemic areas. Since there is a theoretical potential for reversion of the vaccine 
to virulence, ~ is not recommended for non-endemic areas (Assaad et ai., 1983). 
Recommendations and requirements for preparing live attenuated RVF vaccine for veterinary use 
were formulated to ensure a degree of safety and potency of the vaccine, at least equal to that 
recommended by the national control author~ies (WHO, 1984). 
Formalin-inactivated vaccines have been used extensively in southern Africa, Egypt and Israel. 
These vaccines are effective and safe, but are more expensive and at least 2 doses must be given. 
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This type of vaccine is recommended for non-endemic areas or for animals being exported from 
endemic areas (Assaad et a/., 1983). 
Ongoing research on RVF vaccines includes experiments on reassortant vaccines, gene cloning to 
produce recombinant DNA products and synthetic polypeptide vaccines (Meegan & Bailey, 1989). 
A safe, effective formalin-inactivated cell culture-propagated vaccine for RVF is also available for 
humans. It should be used to immunise laboratory and field researchers and to protect persons at 
risk (Eddy et a/., 1981). 
Since enforcement of quarantine of animals is difficult in Africa, quarantine is not generally an 
effective control measure. However, movement of animals from epi400tic areas should be 
restricted to prevent the further spread of RVF (Shope et a/., 1982). 
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2.2. SINDBIS VIRUS 
2.2.1. CLASSIFICATION 
SIN virus is a member of the family Togaviridae and belongs to the genus Alphavirus ('group A' 
arboviruses) (Fraenkel-Conrat, 1985). 
SIN virus is the prototype alphavirus which has served as a model virus in studies on viral 
replication, biochemistry, membrane biogenesis and murine viral encephalitis (Taylor et al., 1955; 
Karabatsos, 1975; Rentier-Delrue & Young, 1980; Olson & Trent, 1985). 
2.2.2. EPIDEMIOLOGY 
2.2.2.1. GEOGRAPHICAL DISTRIBUTION 
SIN virus was first isolated in Egypt in 1952 from Culex mosquHoes collected in the village of 
Sindbis, 30 km north of Cairo (Tayloret al., 1955). 
According to Niklasson (1989) the virus was isolated from humans for the first time in 1961 in 
Uganda. Since then SIN virus has been isolated in several countries in Europe, Africa, Asia and 
Australia. SIN virus is recognised as the most widely distributed of all known arboviruses. 
Human infection by SIN virus is relatively common in the Nile valley of Egypt, due to the close 
proximity of humans, birds and CX. univittatus and Cx. pipiens mosquitoes. An infection rate of 
27% was demonstrated by Taylor et al. (1955) during a survey conducted in Egypt in 1952 to 1954. 
However, prevalence studies of antibodies to SIN virus conducted in 1969, showed an apparent 
decrease in infection rate to 6.3 % (Darwish & Ibrahim, 1975). 
In other areas, such as India, Indonesia, New Guinea and Australia, the virus was readily isolated 
from mosquitoes and birds, but the antibody prevalence in humans was low (Niklasson, 1989). 
Significant antibody presence in humans has been found in Kuwait, Botswana, Kenya, Uganda, 
Guinea Bissau, Nigeria and Senegal (Peters & Dalrymple, 1990). 
In Europe, epidemics were reported from Finland, Sweden and the U.S.S.R. from 1981 to 1984. It 
was noted that human infections with SIN virus usually occurred during the summer months, with a 
peak incidence rate In mid-August in the region between the BO' and 65' north latitudes extending 
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from Sweden (Ockelbo disease), through Finland (Pogosta disease) to the Karelian, U.S.S.R. 
(Karelian fever) (Espmark & Niklasson, 1984; Peters & Dalrymple, 1990; Lvov et al., 1984) . 
Complete ecological studies on SIN virus have been conducted in South Africa since the virus was 
first recognised In 1954. At that time three Isolations of SIN virus were made from Culex 
mosquitoes collected on the Transvaal Highveld (Weinbren et al., 1956). 
A few years later SIN virus was isolated from Cx. neavei and Mansonia uniformis at Ndumu, Natal, 
but it was only in 1963 that SIN virus was proved to cause an illness in man in South Africa. This 
illness was somewhat similar to that caused by WN virus (Malherbe et al., 1963; Mcintosh et al., 
1964). 
Epidemics of SIN virus were reported in 1963, 1967, 1974 and 1984 in South Africa after 
exceptionally high seasonal summer rainfall. Field and laboratory investigations during these 
epidemics implicated simultaneous infections with WN virus (Mcintosh et al., 1964; Findlay & 
Whiting, 1966; Mcintosh et al., 1976; Jupp et al., 1986). 
2.2.2.2. VECTORS AND HOSTS 
During the initial studies on SIN virus in Egypt the virus was isolated from Cx. univittatus, Cx. 
antennatus and An. pharoensis. The virus was also isolated from a hooded crow (Corvus corone 
sardonius), suggesting that birds acted as reservoir hosts (Taylor et al., 1955). 
Since then, SIN virus has frequently been isolated from ornithophilic mosquitoes (Table 2) . Virus 
isolations and a high antibody prevalence in wild and domestic birds have confirmed that avian 
species are the principal vertebrate hosts (Niklasson, 1989). 
Experimental data gained in South Africa shows that the majority of wild bird species tested are 
readily infected by SIN virus. The level of viraemia produced has the potential to Infect mosquitoes 
(Mcintosh et al., 1969). 
The isolation of SIN virus from bat organs in Zimbabwe (BlaCkburn et al., 1982) and from a frog 
(Rana ridibunda) in western Slovakia (Kozuch et a/., 1978) implicates these species as further 
possible reservoirs. It is also of interest than a SIN virus strain was isolated from ticks (Hyalomma 
marginatum) in Sicily (Gresikova et a/., 1978). 
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TABLE 2. SINDBIS VIRUS ISOLATES FROM DIFFERENT SPECIES AND REGIONS 
From mosquitoes 
From birds 
(Niklasson, 1989). 
ex. pipiens/univittatus 
ex. unMttatus 
ex. antennatus 
Anopheles pharoensis 
ex. univfftatus 
ex. theileri 
ex. pipiens 
Ma. africana 
Ma. fuscopennata 
Aedes spp. 
CuJiseta spp. 
Cx.pipiens 
Cs. morsitans 
ex. pipiens ('molestus') 
ex. univittatus 
ex. fritaeniorhynchus 
ex. sinensis 
ex. gelidus 
ex. bffaeniorhynchus 
ex. annulirostris 
As, nonnanensis 
Ae. vigi/ax 
ex. fatigans 
Ma. septempunctata 
ex. pseudovishnui 
ex. fritaeniorhynchus 
ex. geJidus 
ex. tritatmiorhynchus 
Corvus corone sardonius 
Ploceus va/atus 
AcrocephaJus scirpaceous 
Nycticorax nycticorax 
Streptopelia furfur 
MotaciJIa alba 
Gracula refigiosa 
country 
Egypt 
Egypt 
Egypt 
Egypt 
South Africa 
South Africa 
South Africa 
South Africa 
Uganda 
U.S.S.R. 
Sweden 
Sweden 
Sweden 
Israel 
Israel 
Malaya 
Malaysia · 
Malaysia 
Philippines 
Australia 
Australia 
Australia 
Australia 
Australia 
Sarawak 
Sarawak 
Sarawak 
Taiwan 
Egypt 
South Africa 
Czechoslovakia 
U.S.S.R. 
Israel 
India 
India 
The vector for human Infections is not well defined and may vary from region to region. Jupp 
(1973) reported on the feeding habits of mosquitoes on the highveld of South Africa, and found 
that ex. univittatus, which is usually ornithophilic, might become anthropophilic at unusually high 
population densities and could thus infect man. ex. thei/eri was found to be endophagic on man 
and might occasionally be responsible for infections. 
Human infection with SIN virus is considered to be a dead end and humans are not thought to 
contribute to further virus transmission (Mcintosh et al., 1976) . 
ex. univittatus has been implicated as the main enzootic and endemic vector, with the possibility of 
ex. thei/eri as a link-vector, on the inland plateau of southern Africa (Mcintosh et al., 1967; Jupp, 
1973). 
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2.2.3. DISEASE ASSOCIATIONS 
2.2.3.1. ANIMALS 
There is no evidence that SIN virus infection causes disease in animals. Several species of 
domestic and wild animals have been experimentally infected and. with the exception of young 
mice. induced infection is asymptomatic and transient (Taylor et al .• 1955). 
Suckling white mice succumb to infection. Young adult rabbits. hamsters and monkeys resist 
intracerebral (Lc.) inoculation of SIN virus with no ill effects. and specific humoral neutralising 
antibodies can be demonstrated (Taylor et a/ .. 1955). 
Antibody surveys conducted over a wide area in South Africa revealed that sheep and cattle had 
been infected with SIN virus. but no virus isolations were reported (Kokernot et a/ .• 1956; Mcintosh 
et al .• 1962). 
2.2.3.2. HUMANS 
Relatively few human infections with SIN virus have been reported. The first recognised cases of 
SIN virus infection in man occurred in Uganda when the virus was isolated from acute phase blood 
(Niklasson. 1989; Clarence & Dalrymple. 1990). 
Human cases have been reported from South Africa (Malherbe et al .• 1963; Mcintosh et al .• 1964; 
Findlay & Whiting. 1968; Mcintosh et al .• 1976; Jupp et al .• 1986). Zimbabwe (Maar. 1980). Central 
Africa (Clarence & Dalrymple. 1990). Australia (Doherty et al .• 1969; Guard et al .• 1982). Malaysia 
(Tesh et al .• 1975) and north-western Europe (Clarence & Dalrymple. 1990). 
2.2.4. DIAGNOSIS 
2.2.4.1. CLINICAL 
The incubation period for SIN virus infection is usually less than one week (Niklasson. 1989). 
Disease begins typically with a rash and arthralgia. and most described patients have both. The 
rash may precede or follow joint manifestations by 1 or 2 days. Fever is usually not high and may 
even be absent (Espmark & Niklasson. 1984). Malaise. fatigue and headache are common 
occurrences. Anorexia. nausea. pharyngitis and paresthesias can occur in a minority of patients. 
Lymphadenopathy and conjunctivitis are not prominent (Malherbe et a/ .• 1963; Mcintosh et al .• 
1964; Maar. 1980). 
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The rash usually begins on the trunk as scattered macules and spreads to the palms and soles, but 
rarely to the head (Doherty et a/., 1969). Papules, with a tendency to vesiculate, can form on 
pressure points such as soles and palms. The colouration is typical: pink-red vesicles are 
surrounded by a white halo. The rash usually fades within a week leaving a brownish 
discolouration (Mcintosh et al., 1964). In some cases the rash can be haemorrhagic and recur in 
crops (Findlay & Whiting, 1968; Guard et al., 1982). 
Joint involvement is usually multiple. If the disease is acute, it most commonly affects the wrists 
and ankles, knees and elbows, and to a lesser extent the proximal articulations and axial skeleton 
(Mcintosh et al., 1964; Espmark & Niklasson, 1984). The persistence of rheumatic complaints has 
been a dominant feature and they can persist for 5 to 6 years (Niklasson et al., 1988). 
2.2.4.2. LABORATORY 
SIN virus produces CPE in a wide variety of cell cultures, including continuous lines of Vero, HeLa 
and BHK-21 cells and primary chicken and Pekin duck embryo cells (Frothingham, 1955). SIN 
virus also grows in mosquito cell lines, although CPE is not evident (Stollar, 1987; Oelofsen et al., 
1990). However, CPE has been described In clones of Ae. albopictus cells (LT C-7) (Sarver & 
Stollar, 1977). 
The isolation of SIN virus from arthropods or vertebrates is made by i.e. or i.p. inoculation into 3 to 
5 day-old laboratory mice. Mice usually succumb within 2 to 5 days following a short period of 
paralysis (Taylor et al., 1955) . 
Subsequently, cell cultures such as Vero cells have been shown to be sensitive for virus isolation 
and efficient for virus replication, and are usually used in preference to suckling mice (Niklasson, 
1989). 
SIN virus was isolated from acute phase blood from five patients in Uganda in 1961 and from a 
single case in Central Africa by inoculating suckling mice (Peters & Dalrymple, 1990). The virus has 
also been recovered from a skin lesion of a patient in South Africa but rei solation of the agent was 
not successful (Malherbe et al., 1963). 
Antibodies to SIN virus can be measured by HI (Doherty et al., 1969), CF tests (Mcintosh et al., 
1964). IF test, mixed haemadsorption and a neutralisation test (NT) (Skogh & Espmark, 1982; 
Espmark & Niklasson, 1964). 
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Antibodies inttially appear during the first 7 to 10 days of illness, peak soon thereafter, and 
neutralisation or HI titers persist for years (Peters & Dalrymple, 1990). 
IgM antibodies to SIN virus were demonstrated after serum specimens had been fractionated by 
sucrose density gradient ultracentrnugatlon (Guard et al., 1982). The IgM capture ELISA proved to 
be posttive for acute phase sera (Calisher et al., 1985; Niklasson et al., 1988). The detection of IgM 
class antibodies to SIN virus may be of limited value as a diagnostic tool, as IgM antibodies were 
present after 3 to 4 years in almost a third of the patients tested in Sweden after a SIN infection 
(Niklasson et al., 1988). 
2.2.5. PREVENTION AND CONTROL 
Wtth increasing use of Irrigation to satisfy world crop needs, habttats that attract birds and are 
suitable for mosqutto breeding, will become increasingly common. This combination may well lead 
to an increase in human infections wtth SIN virus. Well organised and funded systematic mosquito 
abatement remains the most effective method of prevention of human cases of mosquito-borne 
virus disease, although emergency methods must be employed when outbreaks are imminent 
(Eldridge, 1987). 
Vaccination is not available and the best option for prevention remains personal protection against 
mosquttoes. 
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2.3. WEST NILE VIRUS 
2.3.1. CLASSIFICATION 
WN virus is a member of the family F/aviviridae ('group B' arboviruses) and belongs to the genus 
Flavivirus (Murphy & Kingsbury, 1990). 
2.3.2. EPIDEMIOLOGY 
2.3.2.1. GEOGRAPHICAL DISTRIBUTION 
The first isolation of WN virus was made from the blood of a woman who presented with fever in 
the West Nile province of Uganda in 1937 (Smithburn et a/., 1940). 
No further isolations of WN virus were made until 1950, when WN virus was isolated from the blood 
of three apparently healthy children from the Sindbis sanitary district in Egypt, during a survey on 
poliomyelitis viruses (Taylor et al., 1956). 
Epidemics of WN fever were also recorded in Israel during the summer of 1950, when more than 
500 patients were affected. Further epidemics occurred in areas south-east and to the north of Tel 
Aviv from 1951 to 1954 and in 1957 (Hayes, 1989). 
An outbreak of WN fever was reported in the Rhone delta of the Camargue in France in 1962, with 
subsequent cases reported in 1963 and 1964 (Hayes, 1989). 
The largest epidemic of WN virus yet reported occurred in South Africa in 1974. Following 
exceptionally heavy rains, this epidemic extended over an extensive area of the Karroo and 
northern Cape Province, involving thousands of humans. Field and laboratory investigations during 
this epidemic implicated simultaneous Infections with SIN virus, although to a lesser extent 
(Mcintosh et al., 1976) 
From mid-December 1983 until mid-April 1984 a smaller outbreak of WN fever took place in South 
Africa coincident with an epidemic of SIN virus infection in the Witwatersrand-Pretoria region (Jupp 
et al., 1986). 
WN virus has been isolated in at least 17 countries covering three different geographical regions, 
namely, the Palearctic, the Ethiopian and the Oriental. Serological surveys suggest that the 
geographic range of WN virus may be even more extensive (Hayes, 1989). 
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2.3.2.2. VECTORS AND HOSTS 
Virus isolations and antibody surveys indicate that WN virus can infect a wide range of vertebrate 
species in nature. Virus has been isolated most commonly from man and wild birds (Taylor et al., 
1956; Kokernot & Mcintosh, 1959; Mcintosh et al., 1969; Gaidamovich et aI., 1978). Domestic birds 
such as chickens, ducks and geese are also susceptible to the virus (Taylor et al., 1956; Akov & 
Goldwasser, 1966). 
WN virus antibodies have been detected in large domestic mammals such as horses, mules, 
donkeys, goats, water buffaloes, sheep, pigs, cows and camels (Taylor et al., 1956; Akov & 
Goldwasser, 1966; Hayes et al., 1982; Darwish et al., 1983). Bovine species do not develop a 
viraemia after experimental inoculation, but antibodies are prevalent in cattle (Monath, 1990). 
WN virus antibodies have been detected in the serum of several species of rodents and bats 
(Taylor et al., 1956; Akov & Goldwasser, 1966; Darwish et al., 1983). The susceptibility of laboratory 
mice to experimental WN virus infection, via different routes of inoculation, has been 
demonstrated. (Odelola & Oduye, 1977; Jupp et a/., 1986; George et a/., 1984). 
Rabbits and guinea-pigs develop WN virus antibodies after experimental infection, but do not 
manifest any clinical symptoms of infection (Smtthburn et a/., 1940). Rhesus and cynomolgus 
monkeys developed encephalttis after I.c. and intra-nasal inoculation with WN virus (Pogodina et 
a/., 1983). 
Wild birds have consistently been implicated as the most important hosts in the transmission cycle 
of this virus. Migration of birds can be a mechanism for reintroducing the virus into temperate 
areas on an annual basis where the winters are too cold to support year-round transmission 
activity (Taylor et aI., 1956). 
Man is frequently exposed to infection by WN virus. However, the low concentrations of virus 
found in peripheral blood following natural infections in humans, is probably below the threshold 
necessary to infect most mosquttoes (Mcintosh et a/., 1976). 
Mosquitoes and ticks are the only arthropods that WN virus has been isolated from in nature. 
Isolations of WN virus from various mosqutto species implicate mosquttoes to be the most 
important vector of WN virus throughout its geographical range (Hayes, 1989). 
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The possibility that Cx. univittatus was the vector transmitting the virus to man in an endemic area 
of Egypt was strengthened by the Isolation of WN virus from 23 febrile children during the same 
months that 9 isolations were obtained from Cx. univittatus (Taylor et at., 1956) . 
The importance of Cx. univittatus as the epidemic vector of WN virus on the inland plateau of South 
Africa was shown by the very high infection rate found in these mosquitoes during the 1974 
outbreak. Cx. theilert was the only other mosquito species found to be capable of transmitting 
virus, but to a minor extent (Mcintosh et at., 1976) . 
In south-western Asia, members of the Cx. vishnui complex have been implicated as vectors of WN 
virus, and in the Rhone Delta of France WN virus was isolated from ex. modestus. ex. pipiens has 
been implicated as a possible participant in the transmission cycle of WN virus in the USSR, Egypt 
and Israel. In Pakistan and India ex. fatigans has been suspected as being a vector (Hayes, 1989). 
2.3.3. DISEASE ASSOCIATIONS 
2.3.3.1. ANIMALS 
The isolation of WN virus from naturally Infected domestic animals is a rare occurrence. Two 
isolated cases of naturally acquired WN encephalitis have been reported in horses (Hayes, 1989). 
However, low-level viraemia, antibody production and absence of clinical illness are the general 
rule. 
WN virus was isolated from the blood, brain and spleen of a sick pigeon in Egypt (Taylor et at., 
1956). No other cases of disease in naturally infected wild animals have been reported. 
2.3.3.2. HUMANS 
Humans are certainly involved secondarily to avian infection with WN virus, and most human 
infections are largely 'blind alleys' in the virus transmission chain. Virus concentrations in human 
blood during acute illness are low and an insignificant number of mosquitoes would transmit virus 
after becoming infected from man (MCintosh et at., 1976). 
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2.3.4. DIAGNOSIS 
2.3.4.1 . CLINICAL 
Clinical disease caused by WN virus infection is usually mild. The incubation period of WN virus is 
approximately 3 to 6 days. Disease is characterised by an acute onset of fever ranging from 38 to 
40 °C, lasting 5 to 6 days. Malaise, frontal headache, pain associated wtth eye movement and 
muscle pain are common symptoms. Gastro-intestinal disturbances, a sore or congested throat, 
enlarged lymph nodes and a maculopapular rash have been reported. Convalescence can be 
prolonged, lasting 1 to 2 weeks (Goldblum et a/., 1954; Weinbren, 1955; Marberg et al. , 1956; 
Taylor et al., 1956). 
Mild to severe meningoencephalitis characterised by impaired consciousness, including coma, has 
been reported in elderly as well as young patients (George et al., 1984; Hayes, 1989). 
Anterior myelttis, myocardttis and acute pancreatttis attributable to WN virus infection have also 
been reported from Israel (Perelman & Stern, 1974; Gadoth et al., 1979). 
Arthralgia has been described by Mcintosh et al. (1964) in patients during an outbreak of SIN and 
WN virus infections in South Africa, but this does not appear to be a distinctive feature elsewhere. 
2.3.4.2. LABORATORY 
As with most arboviruses, the isolation of WN virus from arthropods or vertebrates is made in 
laboratory mice. Usually 1 to 4 day old mice are inoculated I.e. or Lp. with an infectious dose of WN 
virus. Death will occur within 2 to 5 days. Adult mice remain susceptible to infection, but the virus 
does not replicate to as high a ttter as in infant mice (Taylor et al., 1956). 
Lethal infection in embryonated hens' eggs produced by WN virus was demonstrated by Taylor et 
al. (1956), but eggs are less susceptible than mice. 
WN virus can infect and produce CPE in a variety of mammalian cell lines including Vero, BHK-21, 
chick embryo and pig kidney cells. The isolation of WN virus from the blood of a patient with 
encephalitis in phytohaemagglutinin-stimulated normal human mononuclear leucocytes, has also 
been reported (Hayes, 1989). 
The mosquito cell lines Ae. aegypti and Ae. malayensis support WN virus replication and CPE has 
been reported in Ae. albopictus and Ae. pseudoscutellaris cell lines (Hayes, 1989; Oelofsen et al., 
1990). 
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The detection of WN virus In a naturally infected bird by an indirect haemagglutination test has 
been reported (Gaidamovich et al., 1978). This technique provides a rapid way of detecting WN 
virus in a viraemic host compared to virus isolation, but the sensitivity is probably lower. 
Virus can be isolated from the blood of patients during the first few days of illness. Studies 
conducted in Israel showed a high virus isolation rate on day 1 and day 2 of illness. No isolations 
were made on day 5 and day 6. Virus was also isolated 2 days prior to the onset of symptoms in 
two cases (Hayes, 1989). 
As early as 1942, an antigenic relationship had been found between WN, Japanese encephalitis 
(JE) and St. Louis encephalitis (SLE) viruses (Smithburn, 1942). Besides JI; and SLE, WN virus was 
shown to cross-react in a PRNT with Murray Valley encephalitis, Usutu, Kunjin, Kokobera, Stratford 
and Alfuy viruses (De Madrid & Porterfield, 1974). 
Two distinct antigenic groups of WN virus, the African-Middle Eastern group and Indian strains, 
were demonstrated when WN virus isolates were tested in a HI test using different immune mouse 
sera (Price & O'Leary, 1967; Hayes, 1989). The antigenic differences between WN virus strains 
from different areas, as well as the existence of subtle antigenic variation within a specific strain, 
were demonstrated by means of monoclonal antibodies (Besselaar & Blackburn, 1988). These 
differences may not be revealed by serological methods employing polycional sera. 
The CF and NT have been most commonly used for the serological diagnosis of WN virus 
infections in man. CF antibodies are first detectable during the second week of illness and are 
clearly demonstrable by the end of the second week. Peak titers are usually recorded 2 to 3 weeks 
after onset, and can stay at this level for 2 to 3 months. After 2 to 3 years, low CF titers can still be 
detected (Hayes, 1989). 
Studies in Israel have also shown that neutralising antibodies in patients with WN virus infection 
developed slower than CF antibodies, but continued to persist at high levels after 2 to 3 years 
(Hayes, 1989). 
The HI test has been used to diagnose WN virus infection in France, South Africa and Israel, but 
paired serum samples, demonstrating a fourfold rise in titer, are not always obtainable. In WN virus 
patients, previously exposed to another group B arbovirus by natural infection or vaccination, the 
CF, NT and HI tests are all broadly reactive, and heterologous antibody titers may be as high or 
higher than the WN antibody titers (Mcintosh et a/., 1976; Feinstein et a/., 1985). 
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An indirect ELISA for the detection of IgG and IgM antibodies in WN virus-infected patients has 
been used successfully in Israel. Feinstein et a/. (1985) found that IgM antibodies to WN virus were 
absent in the first serum sample taken 4 to 7 days after the onset of clinical signs, but could clearly 
be detected in more than 90 % of serum samples taken 23 to 28 days after the onset of illness. In 
the control group of randomly chosen blood bank sera, only antibodies of the IgG class to WN 
virus were detected. 
The detection of IgM antibody to WN virus in the cerebrospinal fluid and serum of a patient with 
WN encephalitis on the fourth day after onset of illness, indicated that the IgM antibody capture 
ELISA method may be very useful in the early diagnosis of WN virus infection (Hayes, 1989). 
2.3.5. PREVENTION AND CONTROL 
No studies on the prevention and control of endemic or epidemic WN virus infections have been 
published. Epidemic activity In man will not be recognised unless the numbers of infected 
mosquito vectors are very high. The rapid reduction in the density of adult mosquitoes by using 
insecticides and avoidance of exposure to vectors, can control WN virus infections. In areas where 
irrigation is extensively practiced, environmental modifications to reduce mosquito breeding sites, 
should be effective (Hayes, 1989). 
No vaccine is available and the development of a vaccine will probably remain a low priority, 
because the majority of cases are mild and epidemics have been infrequent. 
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2.4. WESSELSBRON VIRUS 
2.4.1. CLASSIFICATION 
WSL virus is a member of the family Flaviviridae ('group B' arboviruses) and belongs to the genus 
Flavivirus (Murphy & Kingsbury 1990). 
2.4.2. EPIDEMIOLOGY 
2.4.2.1. GEOGRAPHICAL DISTRIBUTION 
The virus was first isolated from a lamb which died on the farm Magdalena In the Wesselsbron 
district of the Orange Free State during the late summer of 1954/55, following an illness thought to 
be RVF (Weiss et al., 1956). 
One month later, during a survey, WSL virus was isolated from the blood of a febrile field worker in 
the northern part of the Natal Province (Smithburn et al., 1957). 
WSL virus was also isolated from a lamb in the Kroonstad district, Orange Free State, during an 
outbreak of RVF in 1956 (Swanepoel, 1989). 
During 1956 and 1957 an epidemic of an undiagnosed disease among sheep occurred in the 
Middelburg district of the Cape Province. Histological examinations made on specimens which 
were collected during the outbreak, suggested WSL virus involvement (Le Roux, 1959). Confirmed 
WSL virus infection in two field workers during that outbreak implied that infection was acquired 
etther from mosqutto bttes or the handling of infectious post-post-mortem materials (Heymann et 
a/., 1958). 
Although no further clinical WSL virus Infections were described, the virus was isolated from cattle 
in 1974 and 1975 during a RVF epizootic in South Africa and Namibia (Coetzer et al., 1978; 
Swanepoel, 1989). The virus was also isolated from the organs of a cow during a RVF epizootic in 
Zimbabwe in 1978 (Blackburn & Swanepoel, 1980). 
To date WSL virus is known to occur in South Africa, Zimbabwe, Cameroon, Nigeria, Senegal, 
Ivory Coast, Central African Republic, Uganda, Kenya and Thailand (Swanepoel, 1989). 
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2.4.2.2. TRANSMISSION, VECTORS AND HOSTS 
Wesselsbron fever is a mosqutto-borne disease of sheep and, occasionally, human beings. WSL 
virus has been isolated from a variety of mosquito species and tt seems likely that several species 
may act as vectors (Swanepoel, 1989). 
During the WSL epizootic involving sheep in the Middelburg district of South Africa in 1957, virus 
was isolated from various Aedes species mosquitoes (Kokernot et al., 1960), suggesting that these 
mosquttoes can be the main vectors of the virus for sheep. 
Experimental transmission of WSL virus by Culex species has been demonstrated, but these 
species are not considered to be the main vectors on the plateau of southern Africa (Mcintosh, 
1980). 
According to Swanepoel (1989), the isolation of WSL virus from Rhipicephalus muhsamae (ixodid 
tick) could be of epidemiological importance, but no infection and transmission studies were 
performed. Transstadial infection was demonstrated in Omithodorus savignyi (argasid tick), but 
transmission tests were negative. This tick is confined to the northwestern part of the Cape 
Province, but tt Is unlikely to playa role in the transmission of WSL virus. 
Transmission of WSL virus between vertebrate hosts, in the absence of arthropods, was 
demonstrated when transmission occurred between an inoculated and three uninoculated sheep 
(Coetzer et al., 1978). 
2.4.3. DISEASE ASSOCIATIONS 
2.4.3.1 . ANIMALS 
During a routine survey in Nigeria, the virus was isolated from an asymptomatic camel. In newborn 
lambs, WSL fever is characterised by weakness, loss of appettte and often by mortal tty. Older 
lambs, goat kids and calves are less susceptible. Adult sheep. goats and cattle often develop a 
mild febrile infection and a mortality of 20 % has been reported in pregnant ewes. The outcome of 
infection in pregnant animals depends on the stage of pregnancy. Abortions were observed within 
a few days after exposure to the virus during late pregnancy (Swanepoel, 1989). 
Coetzer & Barnard (1977) implicated WSL virus as one of the causal agents in an outbreak of 
hydrops amnii in ewes, fOllowing inoculation with attenuated RVF and/or WSL vaccines in South 
26 
© Central University of Technology, Free State
Africa. Experimental work confirmed that wild and vaccine WSL viruses were responsible for the 
syndrome and severe foetal central nervous system abnormalities. 
Macroscopic examination of lamb carcasses revealed mild to severe icterus with moderate 
hepatomegaly. Histopathological sections of the liver showed extensive necrosis of hepatocytes 
(Le Roux, 1959). 
Apart from humans and several domestic livestock, the only other vertebrate from which WSL virus 
has been isolated is the Namaqua gerbil, Desmodillus auricularis (Mcintosh, 1980). 
2.4.3.2. HUMANS 
The pathogenicity of WSL virus for humans was described by Weiss et al. (1956) when laboratory 
workers were infected with the virus during the course of experiments. Most of the laboratory 
workers became sick, but not critically ill, after an incubation period of 3 to 4 days. WSL virus was 
isolated from the blood of one individual during the febrile reaction. Serological evidence of WSL 
virus involvement was obtained from serum samples in the other workers. 
The first naturally infected human from whom WSL virus was isolated was a member of the 
veterinary field staft who was infected and became ill 7 days after assuming his duties at Lake 
Simbu in Tongaland, northern Natal (Smith burn et al., 1957). 
A further two infections in man were described by Heymann et al. (1958) during field investigations 
of an outbreak of illness among sheep in the Middelburg district of the Cape Province. Both men 
had been frequently bitten by mosquitoes and one had performed post-mortems on infected 
animals. The second individual did not handle any living or dead infected animals. 
From 1955 to 1983 a total of 23 isolations of WSL virus from humans were made. A further five 
human infections were diagnosed serologically. Most of these infections occurred in South Africa 
and laboratory infections were reported from Senegal, Nigeria, the Central African Republic, 
Uganda and the U.S. (Swanepoel, 1989). 
2.4.4. DIAGNOSIS 
2.4.4.1. CLINICAL 
Incubation periods in human infections of WSL virus range from 2 to 7 days. The onset of disease 
is marked by acute fever, rigors, severe headache, tachycardia, anorexia, myalgia and arthralgia. 
27 
© Central University of Technology, Free State
During the fever, which can last up to one week, patients often complain of hyperesthesia of the 
skin and an evanescent maculopapular rash can appear. Hepatomegaly or hepatosplenomegaly 
occurs in some patients and occasionally the serum alanine and transaminase levels are raised. In 
severely ill patients encephalnis, photophobia, blurred vision and mental impairment can occur. 
Fatal cases have not been reported (Mcintosh & Gear, 1981; Swanepoel, 1989). 
Most patients recovered from the acute illness In 1 to 3 days, but muscle pains can persist for 
several weeks (Swanepoel, 1989). 
Seroconversion wnhout any clinical evidence of illness was reported in a laboratory worker (Weiss 
et a/., 1956). 
2.4.4.2. LABORATORY 
The susceptibiltty of wMe mice for WSl virus was demonstrated by Weiss et at. (1956), during the 
isolation of a then unknown virus from a dead lamb. 
Mice of all ages have been found to be susceptible to i.c. Injection of WSl virus. The Incubation 
period varies from 6 days in day-old mice to longer periods in adult mice. When virus is 
administered by the i.p. route, mice under the age of 10 days all succumb. Mice older than 3 weeks 
show no reaction. Mild febrile reactions were observed in guinea-pigs, rabbns, cattle, horses and 
pigs. Serum collected from these animals, in the convalescent phase, had high titers of specific 
neutralising antibodies to WSl virus (Weiss et a/., 1956). 
Intracerebral inoculation of newborn mice probably remains the best method for the primary 
isolation of WSl virus, but since laboratory tests in mice are becoming increasingly expensive, cell 
cultures, used together wnh IF, could prove to be satisfactory for rapid isolation and idenmication 
of WSl virus. 
Way et at. (1976) demonstrated the growth of WSl virus in several cell culture systems and no 
significant differences were found between NT done in mice and cell culture. Serodiagnosis of WSl 
virus infections has been based on the standard arthropod-borne virus techniques of HI, CF and 
NT (Shope & Sather, 1979). 
Homologous antibodies were demonstrated by HI and neutralisation techniques on day 4 after 
experimental infection of WSl virus in sheep and cattle. Maximum tners were obtained from days 7 
to 21. HI titers declined to undetectable levels in 25 months, while NT tners remained detectable in 
cell cultures. CF antibodies were demonstrated on day 10 and became undetectable by week 12 
(Blackburn & Swanepoel, 1980). 
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Cross-reactivity of WSL virus with other flaviviruses occurs and is notably higher in HI than in CF 
and NT. Antibody responses, following a primary WSL infection, could be distinguished from 
cross-reacting flaviviruses by performing quant~ative HI, CF or NT with a range of flaviviruses 
known to occur in the region concerned (Blackburn & Swanepoel, 1980). 
The CF test proved to be specific in monitoring antibody levels in experimental or laboratory 
infections, but sera handled and forwarded to the laboratory under field conditions tended to have 
very low titers, making this test unsu~able for use (Blackburn & Swanepoel, 1980; Swanepoel, 
1989). 
The detection of WSL antibodies In sera of cows and ewes is not significant in an area where the 
virus is known to be prevalent. Since the investigation of teratogenic infection takes place 
retrospectively months after the infection, there is Imle prospect of making a diagnosis of WSL 
virus infection by demonstrating IgM antibody or rising antibody titers in paired serum samples of 
cattle and sheep (Coetzer & Barnard, 1977). 
However, the development and use of an ELISA would facil~ate automation of tests and the 
demonstration of specific IgM antibodies against WSL virus in human sera can be a diagnostic tool 
for the identification of a WSL virus infection In man. 
2.4.5. PREVENTION AND CONTROL 
An inactivated virus vaccine prepared in mouse brain was originally available for vaccination of 
livestock. Presently a freeze-dried veterinary vaccine, prepared from a strain of WSL virus (Weiss et 
al., 1956) which has undergone 110 passages in primary lamb kidney cell cultures and 3 passages 
in BHK-21 cells is available (Swanepoel, 1989). This vaccine is recommended for use in non-
pregnant sheep and cattle in winter or early spring, before mosqu~oes become active. Immunity is 
considered to be durable and revaccination is not recommended. 
General recommendations made to farmers concerning arthropod-borne infections of livestock 
include drainage or treatment of mosqu~o-breeding s~es, housing of sheep at night and moving 
stock to high, wind-swept grazing areas during outbreaks of disease. 
No human epidemics of WSL virus have been identified and ~ appears that human infections are 
sporadic. Human exposures from handling infected animals may account for many infections in 
the sheep-rearing areas of South Africa (Mcintosh & Gear, 1981). 
There is no human vaccine available and protective clothing should be worn by persons handling 
suspected infected organs of domestic animals. 
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2.5. DOT-ELISA 
The dot-ELISA is a modification of the ELISA, which was described by Engvall and Perlmann 
(1972). This technique is based on two important biological phenomena: (i) the extraordinary 
discriminatory power of antibodies, based on the ability of the immune system to produce a 
virtually unlimited variety of proteins (antibodies), each with an affinity for a specific foreign 
compound (antigen or hapten); and (ii) the extremely high catalytic power and specificity of 
enzymes, which may quite often be detectable with great ease (Tijssen, 1985). 
2.5.1. HISTORY 
A method for transporting deoxyribonucleic acid (DNA) fragments from agarose gels to NC by 
capillary forces, was described by Southern (1975) . This method has become known as 'Southern 
blotting'. An improvement to the Southern blot was published by Alwine et al. (1977). Ribonucleic 
acid (RNA) and small DNA fragments, which do not bind sufficiently to NC, were covalently 
coupled to diazobenzyloxymethyl paper by means of capillary blotting. This technique was 
adapted to proteins by Renart et al. (1979) by using polyacrylamide/agarose gels with special 
crosslinkers which could be cleaved easily, to facilitate the transfer. Towbin et al. (1979) transferred 
proteins electrophoretically from polyacrylamide gels on to NC membranes, which were probed 
with two layers of antibody, the second layer being labelled with 1251, fluorescein or horseradish 
peroxidase. 
Since these reports, many adaptations of immunoblotting techniques have been developed and 
applied in an enormous variety of studies. 
The distinctive feature of immunoblotting is the ability to retain the original components of the 
proteins on a solid phase during the course of immunoassay procedures where the resolving 
power of electrophoresis is not needed (Towbin & Gordon, 1984). Thus, antigens can be applied in 
the format of dots or spots (Glenney et al., 1982; Hawkes et al., 1982; Herbrink et al., 1982; Huet et 
al., 1982; Bode et a!., 1984; Heberling & Kalter, 1986; Kalter & Heberling, 1988). This permits the 
use of any desired geometry, and has the further advantages of permitting multiple simultaneous 
assays, high sensitivity and simple operation (Hawkes et al., 1982; Gouvea et al., 1987; Leonardi et 
al., 1990). 
Several techniques have been developed to visualise protein binding onto different membranes. 
The direct nonspecific protein staining is a simple method for the detection of all proteins 
electrophoresed in a gel and transferred to a membrane. Stains such as Coomassie Brilliant Blue, 
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Amido Black. Fast Green. etc. are used (Beisiegel. 1986). 
The direct specific label staining identifies only selected proteins on the membrane. This specific 
label or antibody is labelled (radioactive. fluorescent or by an enzyme mediated colour reaction). 
and is therefore directly visible on the membrane (Beisiegel. 1986). 
The specific detection of particular proteins on the membrane is most frequently achieved by an 
indirect immunolabel. This procedure uses an antibody as the first (direct) probe. This first marker 
binds directly to the protein/antigen on the matrix and is detected by the binding of a second 
(indirect) labelled antibody (Stott. 1989). 
Alternatively to the use of antibodies as second probes. protein A. which. specifically binds to the 
Fc part of many animal immunoglobulins. is often used (Heberling & Kalter. 1986). 
Several detection mechanisms (radioisotopes. fluorochrome-labelled antibodies. gold-labelled 
antibodies. biotin/streptavidin and enzyme-conjugated probes) are used. Advantages of these 
mechanisms are the high sensitivity and easy quantification of antigen. Some disadvantages can 
be the exposure to radiation. rapid fading of results and uncontrolled background staining 
(Beisiegel. 1986; Stott. 1989). 
2.5.2. MEMBRANES 
A variety of membranes are available for immunoblotting. but NC is still the most widely used. 
The use of diazobenzyloxymethyl paper (Alwine et al .• 1979). has the disadvantage of special 
pretreatment of the membrane. before each use. by converting aminobenzyloxymethyl paper to 
diazobenzyloxymethyl paper by diazotisation. This pretreatment of the matrix may result in 
significant non-reproducibility. 
Nylon-based membranes. originally designed and manufactured for liquid and gas filtration. have 
been found to be advantageous in many respects. as they are as thin and as smooth surfaced as 
NC but much more durable. They also have a much higher protein binding capacity (up to 500 
/lg/cm2). although this is highly concentration dependent (Gershoni & Palade. 1982). Proteins are 
not easily washed off as they bind with very high affinity to these membranes. A problem 
encountered is that non-specific proteins tend to bind to the membrane. resulting in very high 
backgrounds. even after prolonged blocking (Gershoni & Palade. 1983). Most of the commonly 
used protein stains (Coomassie Blue. Amido Black, Ponceau S. etc.) bind to nylon membranes, 
making the interpretation of results difficult (Stott. 1989). 
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NC filters were originally designed as 'surface filters' for microfiltration. In the blotting technique 
they serve as 'depth filters' in which the macromolecules concerned are absorbed throughout the 
filter matrix (Gershoni & Palade, 1983). The physico-chemical basis of binding of proteins to NC is 
believed to be largely due to hydrophobic interactions. Observations that non-ionic detergents 
such as Triton X-1 00 or Nonidet P-40 can cause up to 90% detachment of bound protein from the 
membrane, have given rise to this hypothesis (Gershoni & Palade, 1982; Lin & Kasamatsu, 1983). 
This should be taken into account if it is found to be necessary to use washing buffers containing 
detergents in order to reduce non-specific binding. 
NC with a pore size of 0.45 11m is used for most purposes, but low molecular weight polypeptides 
can pass through without binding. Membranes with a pore size of 0.1 11m are recommended, since 
the higher matrix density results in more efficient trapping of low molecular weight proteins (Lin & 
Kasamatsu, 1983). Membranes containing mixtures of NC and cellulose acetate have been found 
to have a low binding capacity for proteins and it is preferable to use NC in the pure form (T owbin 
et ai., 1979) . 
2.5.3. BLOCKING 
It is essential to block the protein binding sites on the membrane to prevent non-specific binding of 
the probe and to eliminate background staining. The blocking agents and conditions used in the 
dot-ELISA will depend on the type of membrane and sensitivity of the system under investigation 
(Stott, 1989). 
Inactivation and blocking with tris (hydroxymethyl) aminomethane, ethanolamine, and gelatine 
have proven to be effective in reducing or eliminating non-specific reactions (Renart et ai., 1979; 
Herbrink et ai., 1982). Gelatine in phosphate buffered saline (PBS) was found to be an adequate 
blocking solution for NC membranes (Holmberg et ai., 1983; Zerbini et ai., 1987), but Towbin & 
Gordon (1984) reported that gelatine alone is not a satisfactory blocking agent. 
Other blocking agems used include bovine serum albumin (BSA) (Towbin et ai., 1979; Gershoni & 
Palade, 1982; Bode et ai., 1984), animal serum (Hawkes et ai., 1982), and haemoglobin (Gershoni 
& Palade, 1982). Powdered nonfat milk gives good, low backgrounds (Heberling & Kalter, 1986; 
Gouvea et ai., 1987; Kalter & Heberling, 1988; Oprandy et ai., 1988). Milk is cheap and readily 
available but it may inhibit specific antibody binding to some antigens (Stott, 1989). 
Non-ionic detergents have been used as blocking agents and have the advantage of being both 
cheap and readily available. Unfortunately they have the severe disadvantage of causing loss of 
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protein by detachment from the membrane (Lin & Kasamatsu, 1983). Tween 20 is claimed to give 
good results with some proteins (Batteiger et a/., 1982; Mohammad & Esen, 1989), but Hoffman & 
Jump (1986) found that some immunoglobulins and several other proteins were dissociated from 
NC by 0.05 % Tween 20 solution. 
2.5.4. WASHING 
Washing is an important step in the dot-ELISA. The membrane has to be washed thoroughly to 
remove any non-specifically bound proteins after incubation. The washing buffers may contain 
various detergents, in addition to BSA or other non-specific blocking proteins, to dissociate 
unwanted proteins from the membrane. However, detergents have to be applied carefully because 
of the possible loss of antigen from the membrane (Hoffman & Jump, 1986). The washing should 
be done with several changes of washing buffer for a sufficient length of time (Hawkes et al., 1982). 
2.5.5. ANTIGEN 
Kafatos et al. (1979) used a dot-blot procedure in which the probe or antigen is applied directly to 
the NC as a dot, instead of being blotted from a gel. 
The visibility of a dot. when using an enzyme-labelled indicator antibody, depends on the contrast 
of the colour generated against the background and is thus dependent on the density of antigen in 
a dot. It is more economical to apply antigens/ antibodies in small volumes (0.5 to 1 pi) in 
concentrated form (Towbin & Gordon, 1984; Heberling & Kalter, 1986). Dry NC easily soaks up 
volumes of the above size range, and binds the material in a tight dot. Larger volumes can be 
applied under vacuum by means of multiple filtration manifolds or other apparatus (Zalis & Jaffe, 
1987). If the antigen is very dilute, successive doses can be applied at the same site, taking care 
that the filter is allowed to dry before each application (Hawkes et al., 1982). 
Crude antigens have been used successfully in the dot-ELISA. Hawkes et al. (1982) described the 
screening of hybridoma clones by using media, as antigen, directly from culture wells. The 
quantitative determination of anti-adenovirus antibodies were demonstrated by Bode et al. (1984) 
by the application of crude adenovirus, propagated in monolayers of Vero cells, to a NC 
membrane in the dot-ELISA. 
Commercially available antigens, normally used in the HI and CF test for different viruses, have 
successfully been applied as antigen source to NC in the dot-ELISA (Hawkes et al., 1982; 
Heberling & Kalter, 1986). 
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2.5.6. ANTIBODIES 
Immunology is recognised as the fundamental reaction evoked by an antigen, usually a protein, to 
form an antibody to react specifically with the antigen (Eisen, 1980). 
Antibodies or immunoglobulins are multichain proteins with an equal number of heavy and light 
chains and have a dual function: (i) recognition of the antigen; and (ii) the activation, after antigen 
recognition, of a variety of biological functions to protect the host. The activation of these 
biological pathways depends on the different heavy chains, and the classification of 
immunoglobulins depends on the structure of these heavy chains (Tijssen, 1985). 
Human immunoglobulins are classified into five classes of antibodies: IgG,lgM, IgA, IgD and IgE. 
Immunoglobulin A occurs in a relative low concentration in the blood, and may represent a first line 
of defence against bacteria and viruses. Secretory IgA can act as a second line of defence against 
antigen invading the respiratory tract (Cooper, 1982). 
Immunoglobulin D is present on the surface of some lymphocytes where it seems to operate as 
mutually interacting antigen receptors for the control of lymphocyte activation and suppression 
(Cooper, 1982). 
Very low concentrations of immunoglobulin E are present in serum and a small proportion of the 
plasma cells in the body synthesise IgE. The main role of IgE would appear to be protection of 
external surfaces of the body by triggering an acute inflammatory reaction (Cooper, 1982). 
Immunoglobulin G is the most common form of antibody in the body and can pass from mother to 
fetus before birth. In most individuals, it is present in high concentrations in the blood after 
exposure to antigen. The demonstration of specific IgG rarely gives any early diagnostic 
information. The presence of specific IgG may, however, be used for the rapid assessment of the 
immune status of a person, which may be valuable if it leads to adequate prophylaxis or 
epidemiological measures (Gardner & McQuillin, 1980). 
Immunoglobulin M appears early after exposure to an antigen, but does not cross the placenta to 
an unborn child. IgM is a pentameric molecule, essentially intravascular, produced early in the 
immune response. It is an effective bacterial agglutinator and mediator of complement-dependent 
cytolysis and is therefore a powerful first-line defence against infections (Roitt, 1988). Specific IgM 
is only occasionally present on the first day of illness but the demonstration of its presence has a 
value for the early diagnosis of an acute virus infection (Gardner & McQuillin, 1980). 
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Rheumatoid factors (RF) can Interfere In certain immunological test systems for antibody or 
antigen detection. These anti-lgG antibodies react preferably with modified. aggregated IgG or with 
antigen. This phenomenon leads to a false positive reaction. particularly In the indirect test method 
for detection of pathogen-specific IgM. where antigen Is bound to a solid phase with the 
employment of ~-chain specific labelled antibodies (TIJssen. 1985). 
If a serum sample contains specific IgG-antlbodles which bind to the solid phase antigen. IgM-RF 
can also bind to the IgG. This results in the reaction of the labelled indicator antibody with IgM-RF. 
since it cannot distinguish between IgM-RF and antigen specific IgM (Figure 1). 
Serum contains 
(virus-)specific IgG and 19M, but no IgM-RF 
Serum contains 
(virus-) specific IgG and IgM-RF, but no (virus-)speci-
fic IgM 
-1 A.AAA 
Result: specifically positive 
Marker enzyme ® antigen-specific IgG 
(alkaline phosphatase) 
Anti-human IgM A 
(~-chain-spec.) antigen-specific 19M 
Result false-positive 
19M-rheumatoid factor 
(lgM-RF) 
-v..: antigen (viral antigen) 
--rJ::' solid phase (polystyrene) ==== 
C-o___ _ _ ._ 
FIGURE 1. EUSA FOR VlRUS-SPECIAC 19M (ZJegoimaJe,"" .• 1085) 
In order to prevent this undesirable reaction caused by IgM-RF. several methods for pretreatment 
of the serum sample with their disadvantages are described in table 3 (Ziegeimaler et a/ .• 1985) . 
Preparations of anti-human IgG (7-chaln) antiserum obtained from sheep by Immunisation with 
immunosorbent-purified human IgG globulin are commercially available. The following are several 
advantages of using these preparations for specific IgM-<liagnostics in the indirect dot-ELISA: the 
interference of RF is eliminated, independently of its concentration, specific IgG-antiboclies are 
neutralised and a competition with specific IgM for antigen is rendered Impossible and the 
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procedure is usually short and simple (Ziegelmaier et al., 1985). 
TABLE 3. COMPARISON OF VARIOUS METHODS FOR AVOIDANCE OF RF INTERFERENCE 
Method Mode of action 
Aggregated 1-globulin Binds RF 
of human or animal origin 
IgG..coated polystyrene particles Binds RF 
Staphylococcal A-protein Binds IgG 
Anti-human IgG (1-chain) Binds IgG 
(Ziegelmaieretal.1985) 
2.5.7. ENZYME-ANTIBODY CONJUGATION 
Disadvantages 
Specificity of antibodies used may not 
be directed against the test antigen. 
Umited capacity; human '1-globulin 
better than animal. 
Umited capacity 
IgG is not bound (serum proportion 
of the totallgG =8%) 
Also binds IgM. 
Unknown 
Several methods for the enzyme labeling of antisera have been described, bu1 commercially 
prepared conjugates are available. These conjugated enzymes are available in pure form, 
conjugated to an antibody wnhout loss of activity, and have a high specific activity. Horseradish 
peroxidase (HRP) or alkaline phosphatase (AP) conjugated antibodies are most widely used in 
ELISA and dot-ELISA (Lennette & Schmidt, 1979; Stott, 1989). 
Peroxidases often occur as multiple isozymes and are widely distributed in plants. HRP is more 
sensnive to contaminants than AP. Water deionised with polystyrene resins is toxic to HRP and this 
enzyme can be inactivated by polystyrene plates, used as the solid-phase in ELISA, if Tween 20 is 
omitted. This enzyme is also very sensnive to the presence of bacteria or bacteriostatic agents and 
is inactivated by oxygen, hypochlorous acid and aromatic chlorocarbons often found in laboratory 
water (Tijssen, 1985). 
The activity of HRP is also inhibited by azides and therefore sodium azide should not be included 
in wash buffers (Stott, 1989). 
Alkaline phosphatases are found primarily in animal tissues and micro-organisms. These enzymes 
are produced from bovine intestinal mucosa and from E. coli. They have considerable differences 
in their properties (the bacterial enzyme has a lower activny than the bovine intestinal enzyme), 
and should not be comparatively assayed under similar condnions (Tijssen, 1985). 
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2.5.8. SUBSTRATES 
Different substrates can be used for detection of enzyme·conjugated antibodies in the dot-ELISA 
(Table 4). HRP substrates become oxidised. usually to an insoluble polymer, when the peroxidase 
catalyses the release of oxygen from hydrogen peroxide. Most of these substrates are potentially 
carcinogenic and can give rise to a high background in the ELISA (Stott, 1989). 
Alkaline phosphatases hydrolyse numerous phosphate esters, such as those of primary and 
secondary alcohols, phenols and amines. Substrates used wnh AP are more soluble than HRP 
substrates, therefore, an increase in sensnivity is obtained with AP (young, 1989). 
TABLE 4. SUBSTRATES USED FOR DETECTION OF ENZVME-CONJUGATED ANTIBODIES 
Enzyme Substrate Color Reference 
Horseradish 4-chloro.1-naphthoI/H2o" Blue Hawkes at al. (1982) 
peroxidase Dresel & Schettler (1984) 
Faye & Chrispeels (1985) 
Dlaminobenzidine/~02 Brown/ de Bias & Cherwinski (1983) 
Purple Young (1989) 
Amlnoethylcarbazole/ Ho!0 2 Blue Clegg (1982) 
o-dianisidine/ Ho!O:i! Orange/ Towbin otal. (1979) 
Yellow 
Alkaline Nitro blue tetrazolium/ Blue Leary at al. (1983) 
phosphatase 5-bromo-4-chloro-idodyl phosphate Blakootal. (1984) 
Naphthol A5-MX phosphate/ fast red Red O'Conner & Ashman (1982) 
B·naphthyl phosphate/ fast blue B Purple/ Turner (1983) 
Brown 
Different colour reactions can be obtained from different substrates, but in the dot-ELISA a definite 
insoluble spot can be observed at the site of the antigen/antibody complex (Table 4). The intensny 
of colour is directly related to the amount of conjugate fixed to the antigen-antibody complex 
(Heberling & Kalter, 1986; Kalter & Heberling, 1988). 
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2.6. IMMUNOFLUORESCENT STAINING 
The IF technique was introduced by Coons et al. (1941), who employed the labile isocyanate 
derivative of fluorescein for conjugation of fluorescein to antibodies or antigens. The conjugation 
procedure was modified by Riggs et al. (1958), who replaced the labile isocyanate radical with 
stable isothiocyanate. Since then, numerous references for IF methods, most applying this 
modification to diagnostic virology, have appeared in the literature (Riggs, (979). 
The IF technique provides a means of observing an antigen-antibody reaction by chemically linking 
a fluorescent dye, such as fluorescein isothiocyanate (FITC), to specific antibody molecules. Such 
labeled antibodies retain the ability to react specifically with respective antigens, and the reaction 
site can be detected with a fluorescence microscope (Emmons & Riggs, (977). Fluorescence 
microscopy is based on the principle that light of a short wavelength such as ultraviolet light will 
excite certain dyes to emit visible light of a longer wavelength which can be observed when the 
correct type of filter is placed between the objective and eyepiece of the microscope (Gardner & 
McQuillin, (980). 
There are three basic staining methods used for the fluorescent antibody technique: 
Direct technique 
In the direct technique, a fluorochrome labelled antibody is used to detect a selected agent 
(antigen) in a specimen or tissue culture. 
Complement staining method 
The complement staining method was devised to enhance the fluorescence of the antigen-
antibody complex by the addition of complement to the system. 
Indirect technique 
The indirect staining technique can be used for detecting and identifying viral antigens as well as 
the serologic response of an individual to a specific viral antigen. Fluorochrome labelled antisera 
against the different classes of human immunoglobulins are commercially available but the 
specificity of such preparations should be thoroughly checked in the test procedure (Riggs, 1979; 
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Gardner & McQuillin, 1980). The indirect technique Is more economical In that a single antiglobulin 
only needs to be labelled. 
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CHAPTER 3 
MATERIALS AND METHODS 
3.1. CELL CULTURE TECHNIQUES 
3.1.1. MATERIALS 
3.1.1.1. CELLS 
Vero and BHK-21 cell lines were ob1ained from the National Institute for Virology, Sand ring ham. 
The passage levels were unknown. 
3.1.1.2. MEDIA 
Growth Medium (pH 7-7.2) 
400 ml sterile Eagles minimum essential medium (MEM) with Earle's salts and L-Glutamine, without 
NaHC03 (Gibco, cat.no. 072·01100P) 
40 ml Foetal calf serum (FCS) (Gibco, cal.no. 013·06290H) 
6 ml of a 5 % NaHC03 solution in H20 (Merck Chemicals, cal.no. 6329) 
2 ml Penicillin, Streptomycin and Neomycin (PSN) stock solution (final concentration of 1 00 un~s, 
100 and 50 ~g/ml respectively) . 
The medium was again sterilised by filtration through a 0.22 ~m membrane filter (Millipore, cal.no. 
SLGS 0250S) and was stored at 4 'C. 
Maintenance Medium (pH 7.2-7.4) 
400 ml MEM (as above) 
8ml FCS 
8 ml of a 5 % NaHC03 solution 
2 ml PSN stock solution 
Sterilised by filtration and stored at 4 'C. 
Phosphate Buffered Saline (pH 7.5) 
9.7 g Dulbecco's PBS (Gibco, cal.no. 076-01300P) 
1000 ml distilled water 
Sterilised by filtration and stored at 4 'C. 
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Trypsin-EDTA 
One vial of Iyophilised trypsin-EDTA (Ethylenediaminetetra-acetic acid) (Gibco, cat.no. 061-()5405D) was 
dissolved in 200 ml sterile, distilled water and sterilised by positive pressure filtration through a 0.22 
Jim membrane. The trypsin-EDTA was dispensed in 20 ml volumes (final concentration of 0.5 g 
Trypsin, 0.2 g EDTA and 0.85 g NaCI/I) into sterile McCartney bottles. The aliquots were stored at -
20 'C. Each aliquot was thawed and opened once only. 
3.1.1.3. ANTIGENS 
The following freeze-dried stock viruses were obtained from the National Institute for Virology, 
Sandringham: 
Strain AN 1830 of RVF virus (passage 5, of a 5 % mouse brain suspension in lactose-phosphate 
buffer (LPB)). 
Strain H 442 of WN virus (passage 4, of a 5 % mouse brain suspension in LPB). 
SIN virus (passage 7, of a 5 % mouse brain suspension in LPB). 
WSL virus (passage 13, of a 5 % mouse brain suspension in LPB). 
3.1.2. METHODS 
3.1.2.1. TRYPSINISATION AND CULTIVATION OF MONOLAYER CELL CULTURES 
The medium from a confluent monolayer of Vero and BHK-21 cells, in 83 cm2 cell culture flasks 
(Nunc, cat.no. 15372), was removed aseptically. The monolayer of each cell line was then washed with 
PBS to remove any traces of medium, and 10 ml trypsin-EDTA solution, preheated to 37 'C, was 
added to the monolayer and left in contact with the cells for 15 to 30 seconds, after which the 
solution was removed. The culture was held at 37 'C until microscopic examination showed that 
the cells had separated. The cells were then suspended in 10 ml of growth medium and triturated 
until a homogeneous suspension was obtained. Cell counts were performed by counting the cells 
in a haemocytometer. 
Cells obtained from trypsinisation were diluted in growth medium to a concentration of 2 x 105 
cells/ml (Vero) and 5 x 10" cells/ml (BHK-21) respectively. Tissue culture flasks were seeded with 
30 ml of cell suspension and incubated at 37 'C for 2 days after which the growth medium was 
changed. Confluent monolayers were obtained 3 days after initiation and the growth medium was 
replaced with maintenance medium. Cell cultures were maintained by a weekly schedule of 
subcultivation. 
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Cell culture tubes were prepared by seeding tissue culture tubes (Nunc, cat.no. 156758) with 1 ml of 
appropriate cell concentrations. Freshly set cultures were sloped and incubated at 37 'C. When the 
monolayers were confluent the growth medium was replaced by 2 ml of maintenance medium, 
which was removed and replaced by FCS free maintenance medium just before the tissue culture 
tubes were infected w~h virus. 
3.1.2.2. ADAPTATION OF VIRUSES TO CELL CULTURES 
Freeze-dried stock viruses (RVF, SIN, WN and WSL) were reconst~uted w~h 1 ml of sterile water 
respectively. Each virus preparation was then further diluted w~h maintenance medium (containing 
no FCS) to a concentration of 1: 1 O. A volume of 1 00 ~I of each virus suspension was inoculated 
into each of 3 Vero cell culture tubes. The infected cell cultures were incub.ated at 37 'C on a roller-
drum apparatus. Control cell culture tubes, containing no virus, were treated in the same manner. 
Each tube was mon~ored on a daily basis for CPE. After a CPE was observed, each virus was 
subcultured into a fresh set of cell culture tubes. After 3 passages, the virus suspensions were 
stored at -70 'C until further use. 
3.1.2.3. TITRATION OF VIRUS IN MONOLAYER CELL CULTURE TUBES; CCID5Q ENDPOINTS 
The amount of infectious virus present in cell culture fluids can be titrated by determining the 
highest dilution of the fluid which produces a CPE in 50 % of the cell cultures inoculated, resulting 
in the 50 % cell culture infectious dose endpoint (CCID50) (Lennette & Schmidt, 1979). 
To determine the CCID50 of RVF, SIN, WN and WSL viruses, logarithmic dilutions of the viruses 
were prepared in FCS free maintenance medium. Pipettes were discarded between each dilution to 
avoid carrying virus particles on the pipette to the next dilution. Each virus dilution was added in a 
volume of 100 ~I/tube to 4 cell culture tubes with a monolayer of cells. Vera cell cultures were 
used for RVF, SIN and WN viruses and BHK-21 cell cultures were used for WSL virus because the 
In~ial titration of WSL virus in Vera cells yielded a very low t~er. Control cultures (inoculated w~h 
1 00 ~I serum free maintenance medium/tube) were included in each t~ration batch of cell culture 
tubes. The inoculated cell cultures were incubated at 37 ' C and observed microscopically at daily 
intervals over a 7 -day period. A specific viral CPE was considered pos~ive, and the CCID5Q end 
point was calculated by the method of Reed and Muench (1938). 
3.1.2.4. PREPARATION OF ANTIGEN IN CELL CULTURES 
Confluent Vero and BHK-21 cell cultures in tissue culture flasks were used for virus propagation. 
The growth medium was removed from a representative culture of Vero and BHK-21 cells. The 
cells were dispersed w~h trypsin-EDTA and counted in a haemocytometer. Growth medium was 
removed from the remaining cultures, and they were infected with adapted seed virus at an 
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infectious dose of 10 viruses per cell. The total volume of fluid in each culture was brought up to 6 
ml with maintenance medium without FCS if the volume of seed virus was less than 6 ml. Cultures 
were incubated at 37 'C for 60 min. Inocula were removed from each culture and a volume of 30 ml 
of serum free maintenance medium was added to each flask. Cultures were incubated until a total 
viral CPE was observed. The cells were then dislodged into the culture fluid by using a cell scraper 
(Nunc, cat.no. 179707). Control antigen (cell cultures without virus inoculation) was collected at the 
same time. Different cultures of the same virus were pooled and after several freeze-thawing cycles 
the antigen suspensions were clarified by centrifugation (7000 g for 30 min at 4 'C). The resulting 
supernatant fluids were then stored at -70 'C until further use. 
3.2. DOT-ELISA 
3.2.1. MATERIALS 
3.2.1.1. NITROCELLULOSE 
Fully supported, 100 % NC sheets (Hybond C-Super, Amersham, cat.no. RPN 1210G) with a pore size of 
0.45 ]1m were used as the solid phase. 
3.2.1.2. ANTIGENS 
Supernatant fluids obtained from the cell cultures (3.1.2.4), and containing RVF, SIN, WN and WSL 
viruses were used. 
3.2.1.3. ANTISERA 
Human serum samples, which tested positive for HI antibodies (National Institute for Virology, 
Sandringham) for RVF (titer; 80 and 160), SIN (titer; 1280), WN (titer; 1024) and WSL (titer; 640), 
were used for the standardisation of the dot-ELISA for detecting IgG antibodies. These serum 
samples were also used as positive controls. 
Human serum samples, known to be positive for the IgM class antibodies against RVF, SIN, WN 
and WSL viruses respectively, were kindly supplied by Dr. N.K. Blackburn (Arbovirus Unit, National 
Institute for Virology, Sandringham). These samples were used for the standardisation of the IgM 
dot-ELISA, and served as positive control sera in the test procedure. 
Patients' sera, accumulated over several years, stored at -20 'C, and previously tested at the 
National Institute for Virology, Sandringham, by the HI test for antibodies against several 
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arboviruses, as well as randomly collected sera from farm workers from several farms in the 
Orange Free State, were included for evaluation of the test. 
3.2.1.4. BLOCKING REAGENTS 
The following blocking reagents (Table 5) were tested to determine the effectiveness of these 
reagents in the dot-ELISA. 
TABLE 5. BLOCKING REAGENTS 
Blocking agent 
PBS-Tween (0.1 %) 
Bovine Albumin Fraction V 
(5%) 
FCS (3%) 
Skimmed Milk (5 %) 
Gelatine (1 %) 
3.2.1.5. CONJUGATES 
Reagents 
1 ml Tween 20 
999 ml PBS 
5 9 Bovine albumin 
100 ml PBS 
3ml FCS 
97ml PBS 
50 9 Skimmed milk powder 
100 ]11 Anti·foam A 
1 111 Thiomersal 
100 ml PBS 
1 9 Gelatine 
100 ml PBS 
Cat No. 
Technikon Chemicals:T21-Q30915 
Gibco: 066.1J1018H 
Gibeo: 013-06290H 
Oxoid: L31 
Sigma: A5758 
BDH: 304164 H 
Dileo: 0143-01 
Goat anti-human IgG, (heavy and light chain specific), conjugated to alkaline phosphatase 
(Calbioehem®, catno. 401453) was standardised in a block titration before use. 
Purified anti-human IgM, (J1-chain specific), prepared in goat, and conjugated to alkaline 
phosphatase (Calbioehem®, cat.no. 401902) was used in a block titration to determine the optimal 
working strength. 
3.2.1.6. SUBSTRATE 
The alkaline phosphatase substrate, 5-Bromo-4-Chloro-3-lndolyl Phosphate p-Toluidine salt 
(BCIP), in conjunction with Nitro Blue Tetrazolium (NBT) as amplifier, were used in the dot-ELISA 
procedure. This substrate system (Table 6) produces an Insoluble end product that is blue in color 
and can be observed visually. 
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TABLE 6. SUBSTRATE SYSTEM 
Stock Solution 
BCIP 
NBT 
Substrate Buffer (PH 9.5) 
Working Substrate Solution 
3.2.1.7. WASHING SOLUTION 
Reagents 
25 mg BCIP tablet 
500 ]11 Dimethylformamide 
10 mg NBT tablet 
1 ml Deionised H20 
12.11 9 Tris Base 
5.84g NaCI 
1 9 MgCI2 
1000 ml deionised water 
HCI to adjust pH 
330 J.l1 NBT stock 
10 ml Substrate buffer 
33 J.l1 BCIP stock 
Cat. No. 
Sigma: B0274 
Sigma: 04254 
Sigma: N5514 
Boehringer 
Mannheim: 708968 
Merck: 6404 
Merck: 5631 
Merck: 9970.0001 
A solution of PBS and Tween 20 (concentration of 0.1 %) was used as washing solution in the dot-
ELISA. 
3.2.1.8. RF ABSORBENT 
RF Absorbent (Behring, cat.no. OUCG 15) was dissolved in 2 ml of sterile distilled water, and was frozen 
in 200 J.l1 quantities at -20 'C until further use. 
3.2.2. METHODS 
3.2.2.1 . ANTIGEN PREPARATION 
Approximately 60 ml of each antigen obtained from the supernatant fluids in cell cultures (3.1.2.4.) 
for RVF, WN, SIN and WSL were concentrated by means of centrifugation (95000 g for 120 min at 
4 'C). The pellet of each 10 ml tube was suspended in 500 J.l1 PBS. Each concentrated virus 
suspension was pooled and then aliquoted into 50 J.l1 volumes which were stored at -70 'C. Control 
antigen was also prepared in the same manner. 
RVF antigen was inactivated before use in the dot-ELISA by incubating 50 J.l1 of concentrated 
antigen suspension at 56 'C for 60 min. SIN, WN and WSL antigens were not inactivated, but all 
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manipulations were carried out in a biohazard laminar flow cabinet. 
3.2.2.2. BLOCKING 
A schematic explanation of the blocking procedure is given in figure 2. 
FIGURE 2. BLOCKING PROCEDURE 
Nitrocellulose membrane 
~ 
Antigen (SIN; 2 ~I) 
~ 
Blocking reagents (Table 5) 
(15 min intervals) 
t 
Wash (3 x PBS-Tween 20) 
t 
SIN posHive control (1 :80) 
(30 min at room temperature) 
~ 
Wash (3 x PBS-Tween 20) 
~ 
IgG Conjugate (1 :5000) 
(30 min at room temperature) 
~ 
Wash (3 x PBS-Tween 20) 
t 
Working substrate solution 
(15 min at room temperature) 
~ 
Wash (tap water) 
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3.2.2.3. STANDARDISATION 
Block titration of conjugate 
IgG 
A nitrocellulose sheet (5 x 3 cm) was prepared by drawing a grid pattern (1 cm2) with a pencil. 
Logarithmic dilutions of concentrated SIN antigen were prepared in PBS (10-1 to 10-3). One ~I of 
each antigen dilution was spotted onto 5 grids in a row with a pipette (Labsystems Rnnpipette, cat.no. 
4027000), starting with the concentrated antigen. The antigen spots were allowed to dry. The NC 
sheet was submerged in blocking reagent and allowed to react for 30 min. after which it was 
washed with 3 consecutive changes of PBS-Tween 20 (washing solution) by flooding a Petri dish 
with washing solution and rocking it gently. 
A reference human serum with a HI titer of 1024 for SIN antibodies was diluted to a concentration 
of 1:40 in PBS. Approximately 4 ml of serum solution was layered onto the NC sheet and allowed 
to react at room temperature for 30 min. The NC sheet was washed as previously described. 
The NC sheet was then cut into strips containing different dilution factors of antigen and each strip 
was placed in a Petri dish. The NC membrane was handled throughout with forceps. 
The goat, anti-human IgG conjugate was diluted in PBS (1 :500, 1 :1000, 1 :2000, 1 :3000 and 1 :4000) 
and approximately 1 ml of each concentration was placed on each NC strip with the antigen and 
antibody complex and incubated for 30 min at room temperature. The excess conjugate was 
removed by submitting the strips to another wash cycle. 
Working substrate solution (Table 6) was added to each strip and the substrate solution was 
allowed to react for 15 min. The reaction was stopped by washing the strips in tap water. 
IgM 
The same test procedures as for IgG were followed and a schematic representation of the 
concentration of the goat, anti-human IgM is listed in figure 3. Serum samples used for IgM 
standardisation, as well as for evaluations, were first treated with an equal volume of RF absorbent 
for 15 min at room temperature before application. 
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2 3 4 
: I I I I I 
Row A.B,C = SIN concentrated antigen (1 I't) 
Row A c SIN IgM positive serum (1 :40) 
Row B = SIN IgM positive serum (not treated 1:40) 
Row C = Control serum (Anti·Rubelia IgM positive 1 :40) 
Column 1 = Conjugate 1:1000 Column 3 = Conjugate 1:3000 
Column 2 = Conjugate 1:2000 Column 4 = Conjugate 1:4000 
FIGURE 3. BLOCK TITRATION OF CONJUGATE FOR IgM DETERMINATIONS 
Block titration of antigen and serum 
The concentration of the antigen and sera for each virus was determined by block titrations as 
schematically illustrated in figure 4. The volume of antigen spotted on the NC was standardised at 
1 Ill/grid. Approximately 1 ml of serum dilution was added to each column. 
Serum dilutions 
A jl: 
E 
F 
A = Concentrated antigen (1 Ill) 
B - Diluted antigen (10.1) 
C and D = Alternative antigen (concentrated) 
E = Vera control cells 
F = Negative serum control 
Column 1 to 8 = Serum dilutions (1 :20; t :4O etc.) 
Column 9 = Negative serum (1 :20) 
2 3 
FIGURE 4. BLOCK TITRATION OF ANTIGEN AND ANTISERUM. 
3.2.2.4. DOT-ELISA 
4 
The following method was used in the test procedure: 
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One ~I of the concentrated antigen of RVF, SIN, WN, WSL and control was spotted respectively on 
blocks of 5 cm2 NC strips. The NC membrane was allowed to dry. To block the un reacted protein-
binding sites, the strips were submerged in PBS-Tween 20 (0.1 %) solution in a Petri dish and left at 
room temperature for 30 min. The strips were then washed with washing solution (3 cycles). 
Serum samples were diluted in PBS at a concentration of 1 :80 (lgG) and 1 :40 (lgM) respectively. 
For IgM determinations the diluted serum samples were treated with equal volumes of RF 
Absorbent (final concentration of serum: 1 :80). 
The strips were then flooded WITh approximately 1 ml of serum dilution and allowed to react for 30 
min. Positive control sera were included in each batch to be tested. After the strips had been 
washed, conjugate (diluted to a concentration of 1 :4000 for IgG and 1 :3000 for IgM) was added. 
Following an incubation of 30 min the strips were washed and then submerged in working 
substrate solution. The substrate solution was allowed to react for 15 min after which the strips 
were washed WITh tap water. The NC was allowed to dry before visual interpretation of results. 
PosITive reactions were determined by a visual cut-off point. A clearly visible blue spot was 
regarded as a posITive result. Reactions lighter in intensity than that of the positive control were 
interpreted as negative. 
3.3 IMMUNOFLUORESCENCE 
A modification of the indirect IF test as described by Shope & Sather (1979) was used. 
3.3.1 . MATERIALS 
3.3.1.1. REAGENTS 
PBS. 
Acetone at 4 'C. 
Goat anti-human IgM (~-chain) FITC conjugate (Sigma, cat.no. F5384). 
Goat anti-human IgG (whole molecule) FITC conjugate (Sigma, cat.no. F3512). 
RF Absorbent 
Evans blue stain (stock solution) 
1 g Evans blue powder (Merck, cat.no. 3169) 
100 ml Distilled water 
Dissolve the powder in the distilled water and store the stain solution at 4 'C. 
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3.3.1.2. ANTIGENS 
RVF, SIN, WN and WSL virus (passage 3 in Vero cells, as prepared in 3.1 .2.2) 
3.3.1.3. ANTISERA 
Human serum samples (3.2.1.3). 
3.3.1.4. MISCELLANEOUS 
Teflon-coated 8 well multitest microscope slides (flow Laboratories, cat.no. 60-408'()S). 
Nikon Optiphot microscope, equipped with epi-fluorescence accessories, ultraviolet filter cassettes 
and a high pressure mercury lamp. 
3.3.2. METHODS 
Infected cell cultures were prepared as described in 3.1.2.4. Once a CPE was observed, the cells 
were dislodged from the cell culture flask and centrifuged at 7000 g for 30 min at 4 'C. The pellet 
was reconstituted into 1 ml of serum free maintenance medium. To each virus-infected suspension, 
the same volume of control cells (non-infected Vero cells) was added. After thorough mixing, 25 111 
of cell suspension was spotted onto each well of the teflon-coated, 8 well multitest microscope 
slides. The slides were dried in air and then fixed in acetone at 4 'c for 10 min. The slides were 
stored at -70 'c until use. 
3.3.2.1. STANDARDISATION 
The optimal working dilution of the goat, anti-human IgG and IgM FITC conjugate and patient's 
sera were determined. 
Double dilutions (starting at 1 :4) of positive, as well as negative control sera were diluted in PBS to 
a final dilution of 1 :32. Each serum dilution was added in a volume of 25 111 to 3 wells of a 
previously prepared antigen-coated multitest microscope slide. The slides were incubated in a 
humid chamber at 37 'c for 30 min. The slides were then washed with 3 cycles of PBS for 10 min. 
The FITC conjugate for IgG was diluted in PBS in concentrations of 1 :8; 1 :16 and 1 :32. Each 
concentration of conjugate was added in a volume of 25 111 to a well of the microscope slide 
containing a different dilution of control serum. The slides were incubated at 37 'C for 30 min, and 
then washed in PBS for 10 min. Counterstaining was done with Evans blue (final concentration, 
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1:10000 In H20) for 3 min at room temperature. The slides were washed wnh PBS and allowed to 
dry before examination under the fluorescence microscope. 
To determine the optimal working dilution of the IgM FITC conjugate, posnive, negative and a RF 
positive serum were diluted at double dilutions starting at 1 :4. Each dilution of serum was treated 
wnh an equal volume of RF Absorbent (reconstituted to a volume of 1.5 ml wnh distilled water), and 
incubated at room temperature for 15 min. A volume of 25 ]11 of the different dilutions of control 
samples were added to three wells of previously prepared IF slides. The slides were incubated at 
37 ·C for 120 min after which they were washed with 3 changes of PBS for 10 min. The conjugate 
(concentrations of 1 :50, 1 :100 and 1 :200) was added to each well of different serum dilutions. The 
test was further performed as described for IgG standardisation. 
3.3.2.2. TEST PROCEDURE 
In the test procedure, serum samples were diluted to 1 :16 with PBS and each serum sample was 
tested for RVF, SIN, WN and WSL antibodies of the IgG class. The working dilution of the goat, 
anti-human IgG FITC conjugate was determined to be 1 :16. 
Volumes, incubation times, temperatures and wash cycles were followed as stated in 3.3.2.1. 
For IgM determinations the serum samples were tested at a final dilution of 1: 1 0, and the goat, anti-
human IgM FITC conjugate gave a satisfactory result at a concentration of 1 :50. 
The prepared IF slides were allowed to dry in the dark before examination by fluorescence 
microscopy by two independent observers. ~--QOK'\S 
\ _~\S ~OPERi~ 
3.4. STATISTICAL ANALYSIS OF DATA 'T\",\E bf 1'\'\E 
\) 3 AUG \~ 
3.4.1. KAPPA STATISTICS \ECHN\l<.~;~ 
fRE.E 51 
Kappa statistics (K) (Fisher and Van Belle, 1993) wer applied to the results obtained in the dot-
ELISA and IF test to measure the amount of agreement between the methods, where 
K = 
1 - Pe 
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Po = observed probability of concordance between two methods 
Pe = expected probability of concordance between two methods 
Evaluation of Kappa statistics: 
< > 0.75 denotes an excellent amount of agreement 
0.75 < < > 0.4 denotes a good amount of agreement 
0.4 < < > 0.0 denotes a marginal amount of agreement. 
3.4.2. TWO BY TWO CONTINGENCY TABLE 
Data obtained from the dot-ELISA, IF, and HI test were submitted to the 2 x 2 contingency table to 
analyse the sensitivtty and specificity of the dot-ELISA versus the IF and HI test. 
Independent 
variable 
+ 
a = true positive 
b = false positive 
c = false negative 
d = true negative 
n = total specimens 
Sensttivtty = a / a + c 
SpecHictty = d / b+d 
Accuracy = a+d / n 
Dependent variable 
+ 
a 
c 
a+c 
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CHAPTER 4 
RESULTS 
4.1. STANDARDISATION 
4.1.1. BLOCKING REAGENTS 
The different blocking solutions tested gave significantly different background staining (Table 7). 
The use of PBS-Tween 20 (0.1 %) and FCS (3%) as blocking reagents gave the lowest background 
staining at the time interval of 30 min, while Gelatine (1 %) and skimmed milk (5 %) gave a high 
background staining at the same time interval. 
TABLE 7. BACKGROUND STAINING WITH DIFFERENT BLOCKING REAGENTS 
Blocking reagent 
Gelatine (1 %) 
Skimmed milk (5%) 
PBS-Tween 20 (0.1%) 
FCS (3%) 
Bovine albumin Fraction V (5%) 
o = No background staining 
1 = Background staining 
2 = High background staining 
4.1.2. CONJUGATES 
15mln 
2 
2 
1 
1 
2 
. 
TIme 
30 min 45 min 
2 1 
2 2 
~ 
0 0 
0 0 
1 0 
80 min 
1 
2 
0 
0 
0 
The working dilutions of the goat, anti-human immunoglobulin G and M for the dot-ELISA were 
determined to be 1 :3000 and 1 :4000 respectively. 
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4.1.3. ANTIGENS 
The optimal antigen concentration of each virus was determined in the block titration. Figure 5 
clearly shows that a posttive reaction was obtained with concentrated antigen in each case of the 
titration of RVF, SIN and WN viruses. Only concentrated antigen was spotted in the case of WSL 
virus. No or minimal cross-reaction was observed between RVF, SIN and WN viruses (Figure 5 
a,b,d). In the case of WSL antigen, cross-reaction was observed between RVF, WN and SIN 
antigen (Figure 5 c). 
4.1.4. ANTISERA 
As the posnive control sera yielded reactions up to dilutions of 1 :80 or higher, tt was decided to use 
a serum dilution of 1 :80 in the test assay for detecting IgG (Figure 5), as well as IgM antibodies 
(Figure 6) against RVF, SIN, WN and WSL viruses. In the block tttration for RVF virus (Figure 5a) 
two different positive serum samples were used, the second sample giving a higher titer for RVF 
IgG antibodies and was subsequently used as control in the test assay. 
4.1.5. IMMUNOFLUORESCENCE 
In the IF test for IgG and IgM evaluations, the working dilution of patient's sera was determined to 
be 1 :16 and 1 :10 respectively. It was necessary to dilute the conjugate 1:16 (lgG) and 1 :50 (lgM) 
for satisfactory results. Photographic examples of IF for RVF, SIN, WN and WSL (lgG antibodies) 
are listed In the appendix. 
4.2. SEROLOGICAL RESULTS 
For the evaluation and validation of the dot-ELISA, 100 serum samples were tested for IgG and IgM 
antibodies to RVF, SIN, WN, and WSL viruses. 
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4.2.1. IgG ANTIBODY DETERMINATIONS 
The antibody results obtained for each serum sample for the different viruses in the dot-ELISA and 
IF test are listed in the appendix. 
A summary of the statistical results obtained in the dot-ELISA and IF test, for each virus, is supplied 
in table 8. 
4.2.1 .1. RIFT VALLEY FEVER VIRUS 
All the sera which tested IgG antibody positive in the IF test (Table 8) for RVF antigen, were positive 
in the dot-ELISA (sensttivtty, 100%). Ten sera tested posttive in the dot·ELlSA but negative in the IF 
test for RVF antibodies (specifictty, 87%). The amount of agreement between the two surveys was 
good « = 0.7259). 
4.2.1.2. WEST NILE VIRUS 
The comparison of antibody testing (lgG) for WN virus in the dot-ELISA wtth the IF test as 
standard, showed a sensttivity of 100% (Table 8). One serum sample tested positive wtth the dot· 
ELISA but negative with the IF test (specilictty, 98%). The Kappa value (0.9605) denoted an 
excellent amount of agreement, and the statistical calculation of the accuracy of the test was 99 %. 
4.2.1.3. SINDBIS VIRUS 
Results obtained for SIN virus IgG antibodies revealed a sensitivtty of 88% and a specifictty of 86% 
(Table 8). Thirteen sera tested positive with the dot·ELlSA and negative wtth the IF test. One 
specimen tested positive wtth IF but negative with the dot·ELlSA. The amount of agreement 
between the two surveys was good. 
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4.2.1.4. WESSELSBRON VIRUS 
Results for WSL antibody (lgG) testing showed a sensitivity of only 54%. Five serum samples 
tested positive with the dot-ELISA, while 6 serum samples tested positive for IF antibodies 
(specificity, 94%). The Kappa value of 0.490 denoted a good amount of agreement and the 
accuracy was calculated to be 89 %. 
TABLE 8. RESULTS OF DOT-ELISA IgG VERSUS IF TEST AS STANDARD (n =100) 
Virus True False True False Sensitivity Specificity Kappa Accuracy of 
Positive Positive Negative Negative % % test (%) 
RVF 21 10 69 o 100 87 0.7259 90 
WN 47 52 o 100 98 0.9605 99 
SIN 7 13 79 88 86 0.6022 86 
WSL 7 5 82 6 54 94 0.4900 89 
The HI ttters of 33 serum samples were known and by using these results as the standard test, the 
results obtained in the dot-ELISA were compared in table 9. The reproducibility of each test varied 
from excellent (WN virus: <=0.8412), to marginal (WSL virus: <=0.2303). For RVF virus «=0.6731) 
and SIN virus «=0.7390) a good amount of agreement was obtained. 
TABLE 9. RESULTS OF DOT-ELISA IgG VERSUS HI AS STANDARD (n = 33) 
Vlrus 
RVF 
WN 
SIN 
WSL 
True false True False 
Positive Positive Negative Negative 
6 2 23 2 
19 2 11 
10 19 3 
3 2 19 9 
59 
Sensitivity Specificity Kappa 
% % 
75 92 0.6731 
95 85 0.8412 
77 95 0.7390 
25 90 0.2303 
Accuracy of 
test (%) 
88 
91 
88 
67 
© Central University of Technology, Free State
4.2.2. 19M ANTIBODY DETERMINATIONS 
Results obtained for RVF, WN, SIN and WSL determinations of IgM antibodies in 100 serum 
samples by the dot-ELISA and IF tests are listed in the appendix. 
The calculated statistical results for the IgM determinations are summarised in table 10. 
In the case of RVF, SIN and WN virus, for IgM antibodies, a 100% correlation between the dot-
ELISA and IF test was observed. No positive results were obtained for WSL virus IgM antibodies in 
both the dot-ELISA and IF test. 
The serum samples which tested positive for IgM antibodies for the different viruses, yielded 
negative results in the latex test for RF. 
TABLE 10. RESULTS OF DOT-ELISA 19M VERSUS IF TEST AS STANDARD (n = 100) 
Virus 
RVF 
WN 
SiN 
WSL 
True False True False 
Positive Positive Negative Negative 
4 
o 
o 
o 
o 
o 
99 
96 
99 
100 
o 
o 
o 
o 
Sensitivity Specificity Kappa 
% 
100 
100 
100 
% 
100 
100 
100 
100 
>0.75 
>0.75 
>0.75 
>0.75 
* Mathematical manipulation of a 0 value by adding 0.5 to all values of formula 
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Accuracy of 
test (%) 
100 
100 
100 
100 
© Central University of Technology, Free State
CHAPTER 5 
DISCUSSION 
The diagnosis of viral infections requires the use of rapid and sensitive assays, therefore the need 
to develop easy and inexpensive assays which are not commercially available. Among the 
important viral infections occurring In the Orange Free State are mosqutto borne arbovirus 
Infections. According to Mcintosh (1980), the prevalent arboviruses found in the Orange Free State 
are RVF, SIN, WN and WSL viruses. It was thus decided to develop a combined rapid test for 
detecting antibodies against these viruses in human blood specimens as no commercial tests are 
available. 
In the development of the dot-ELISA for the detection of IgG and IgM antibodies to RVF, SIN, WN 
and WSL viruses, the antigens used were crude virus preparations. They consisted of clarHied 
culture supernatant media, concentrated by centrifugation and stored at - 70 ' C for several months 
before use. Although crude preparations of viruses were used successfully in the dot-ELISA (Bode 
et a/., 1984; Gouvea et al., 1987; Boctor et al., 1989; Leonardi et al., 1990), concentrated antigens 
enhanced the sensitivtty of results (Heberling & Kalter, 1986). 
It was found that 1 ~I of crude concentrated antigen gave a sufficient size dot to distinguish 
between a positive and negative result, thus allowing for a minimal volume of antigen in this test. 
This contributed in making this technique particularly valuable when dealing with antigens that are 
expensive and difficult to obtain or to purHy. 
Hawkes et al. (1982) found that binding of the antigen to NC appears to be instantaneous and in 
experiments with the application of various volumes of antigen spotted, tt was found that a spot 
with the application of 0.1 ~I antigen was still clearly visible. This was the smallest volume applied 
to NC with commonly available equipment. 
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The instantaneous binding of antigen to NC was confirmed by the size of the antigen dot on the 
NC which never exceeded the limit of the grid. Although a 1 /11 drop of antigen wetted beyond the 
edge of the block, no mixing of antigen occurred and the colour intensity and the dot size of the 
positive control sera were satisfactory. 
Antigens associated with viruses considered to be highly pathogenic for humans, could be 
inactivated with a psoralen derivate and long-wavelength ultraviolet light irradiation for use in the 
dot-ELISA (Heberling & Kalter 1986). This procedure is not readily available and a method for heat 
inactivation (Saluzzo et a/. 1988) was modified for use in the dot-ELISA for RVF antigen. SIN and 
WN antigens yielded no reactions in the dot-ELISA after heat inactivation and it was thus decided 
to use Infectious antigen in the assay, the test procedure being performed in a biohazard laminar 
flow cabinet. 
The stability of the viral antigens on dried NC membranes was not determined as the storage 
facilities for antigen were readily available and the dotting procedure could easily be performed. 
However, it was found that antigen stored at 4 °C for 3 months still performed adequately in the 
block titration (Figure 5d), except that in the WSL block titration (Figure 5c) reactions occurred in 
row C. This indicated probable contamination of the WN antigen as a reaction was observed with 
the negative control serum as well as the Vero control cells. 
While testing for different blocking reagents in the dot-ELISA, it was noted that gelatine and 
skimmed milk gave a blue background staining, even after 60 min adsorption, making it impossible 
to recognise the antigen/antibody complex on the NC membrane. This was in contrast to 
Heberling & Kalter (1986) and Lavanchy et al. (1990) who found a solution of 5 % nonfat dry milk in 
PBS containing 0.01 % Anti-foam A and 0.0001 % merthiolate and a solution of 1 % dry powder 
milk in Tris-buffered saline to be excellent blocking reagents. However, the incubation period in 
both cases was overnight at room temperature. 
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WITh PBS-Tween 20 (0.1 %) and FCS (3 %) as blocking reagents, no background staining occurred 
after 30 min incubation (Table 7). Hoffman and Jump (1986) reported that several immunoglobulins 
and proteins dissociated from NC using PBS-Tween 20, but excellent results were obtained in this 
study. Batteiger et al. (1982) and Leonardi et al. (1990) also claim that PBS-Tween 20 as blocking 
reagent gives good results In the dot-ELISA and because of the advantage of being both cheap 
and readily available IT was decided to use PBS-Tween 20 in the dot-ELISA. 
Data supplied in table 8 show that the sensitivITy of the dot-ELISA was comparable to that of the 
conventional IF test. The dot-ELISA recognised all the pOSITive sera that tested pOSITive WITh the IF 
test for IgG determinations for RVF and WN. 'False positive' results as reported in table 8 can be 
Interpreted as greater senSITivity of the dot-ELISA. Greater senSITivity of the dot-ELISA detection of 
antibodies to several viruses as compared to the IF test were reported by Heberling and Kalter 
(1986) and Kalter and Heberling (1988). Two serum samples which tested positive with the dot-
ELISA and negative WITh the IF test for RVF IgG antibodies were tested by a NT In Vero cell 
cultures, and neutralised RVF virus at a dilution of 1 :20 (data not supplied). Therefore, the dot-
ELISA is probably a more senSITive test. The single negative result obtained by the dot-ELISA which 
was positive in the IF test for SIN IgG antibodies cannot be explained. The test was not repeated 
due to insufficient serum sample and the result may thus be due to technique. 
The low senSITivity obtained with the dot-ELISA for WSL IgG antibodies compared to the IF test 
may be due to cross-reaction with the other antigens. This phenomenon was observed in the block 
titration of WSL antigen (figure 5c) where positive WSL serum reacted with RVF, WN and SIN 
antigens. The interpretation of WSL IgG results in the dot-ELISA was also difficult. A colour 
reaction, with nearly the same intensITy as the positive control, was observed in the test, making 
the decision for a positive or negative result nearly impossible. WSL is known to cross-react 
serologically with other flaviviruses, but homologous WSL titers can be distinguished from 
heterologous flavivirus titers after a primary WSL infection by performing serological tests with a 
range of flaviviruses known to occur in the region concerned (Blackburn and Swanepoel, 1980). 
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In the acute phase of an infection, or shortly thereafter, the detection of specific IgM antibodies is 
diagnostically useful. Rheumatoid factors of the IgM class can cause a false-positive result in 
Indirect serological methods for the detection of specific IgM antibodies, if the sample also 
contains specific IgG antibodies (Tijssen, 1985; Ziegelmaier et at., 1985). Besselaar et at.(1989) 
found non-specific staining in the IF test when testing untreated sera for SIN and WN IgM 
antibodies. In this study both the dot-ELISA and IF test sera were pretreated with RF Absorbent 
(anti-human IgG) to neutralise IgG and to eliminate the considerable skill and experience required 
to distinguish between true posnives and non-specific staining in the assays. 
The correlation of IgM results In the dot-ELISA and IF test was 100%, making it difficult to identify 
the better test. A definne advantage of the dot-ELISA is the relative crude antigen needed on the 
solid phase, as well as one dilution of serum to be tested for multiple antigens at the same time. 
The dot-ELISA can be performed in a short time and visual evaluation of the colour reaction 
eliminates expensive laboratory instrumentation. The used membranes can also be kept as a visual 
result for some time without any noticeable change in colour. These characteristics enable the use 
of the dot-ELISA for the rapid screening of large numbers of sera under field trial condnions, since 
a single dilution of serum under test reacts with strips dotted wnh the various antigens of RVF, SIN, 
WNandWSL. 
Although interpretation of the dot-ELISA was visual and, therefore, subjective, positive and 
negative reactions could easily be distinguished as concurrence in reading of results by two 
Independent observers were reached in the dot-ELISA as well as the IF test. The test could be 
automated using a recording densitometer as shown by Furuya et at. (1984) , but the utilny of the 
dot-ELISA for routine diagnosis lies in its simplicny and rapidtty in obtaining a posnive or negative 
result. 
In conclusion, the dot-ELISA is a simple, rapid and sensnive assay for detecting both IgG and IgM 
antibodies to RVF, WN, SIN and WSL viruses in human sera. The test can be completed in 2 to 3 
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hours and can be used in the smallest laboratory or under field conditions. where sophisticated 
equipment and highly trained technical staff may not be available. It should prove to be useful in 
human seroprevalence and seroepidemiological studies on arboviruses. 
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SUMMARY 
Arboviruses are maintained in nature through transmission between susceptible vertebrate hosts 
by haematophageous arthropods. Mosquttoes are the most important arbovirus vectors and are 
responsible for the most prevalent arbovirus infections in the Orange Free State namely, RVF, WN, 
SIN and WSL. 
With generalised 'flu-like' clinical symptoms, a conclusive diagnosis for arbovirus infections can 
only be made by the laboratory, but commercial diagnostic assays testing for virus specific IgG 
and IgM for RVF, WN, SIN and WSL viruses are not available. 
A dot-ELISA was developed by using a NC membrane as solid phase on which crude concentrated 
antigen preparations of RVF, WN, SIN and WSL viruses were spotted. The use of enzyme-
conjugated anti-human immunoglobulins of the IgG or IgM class, with an insoluble substrate, 
produced visual results to distinguish between the IgG and IgM class antibodies of the previously 
mentioned viruses. 
Serological data obtained In the dot-ELISA were compared with results obtained in the IF and HI 
test to determine the sensttivtty and specifictty of the dot-ELISA for each virus. 
The sensitivtty of the dot-ELISA versus the IF test for IgG antibodies varied from: RVF 100 % 
(specificity, 87 %); WN, 100 % (specificity, 98 %); SIN, 88 % (specificity, 86 %) and WSL, 54 % 
(specifictty, 94 %). 
A 100 % correlation was observed between the dot-ELISA and IF test for RVF, WN, SIN and WSL 
antibodies of the IgM class, providing 100 % sensttivity and specifiCity for each virus. 
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The simplicity, low costs, and demonstration of IgM and IgG antibodies in the dot-ELISA should 
prove to be of diagnostic value in the early detection of arbovirus infection as well as in 
seroepldemlological studies on arboviruses. 
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SAM EVAlTl NG 
Die arbovirusse word in die natuur deur virus oordraging tussen geskikte werweldier gashere en 
bloedsuiende artropode onderhou. Muskiete is die belangrikste arbovirus vektore en is in die 
Vrystaat vir Slenkdalkoors-, Sindbis-, Wesnyl- en Wesselsbronvlruslnfeksles verantwoordellk. 
Die simptome van arbovirusinfeksies kan verwar word met die van 'n "griep-beeld", daarom is dit 
belangrik om 'n diagnose deur laboratoriumtoetse te bevestig. Kommersiiile toetse om te toets vir 
spesifieke IgG en IgM antiliggame teen Slenkdalkoorsvirus, Sindblsvirus, Wesnylvirus en 
Wesselsbronvirus is nie besklkbaar nie. 
'n Dot-ensiemgebonde immuunsorbantessal (dot-ELISA) is ontwikkel deur gebruik te maak van 
nitrosellulose membrane waarop ongesuiwerde, gekonsentreerde antigeen van 
Slenkdalkoorsvirus, Wesnylvirus, Sindbisvirus en Wesselsbronvirus in klein hoeveelhede gebind 
word. Die gebruik van ensiem-gekoppelde anti-mens immuunglobulien verskaf 'n sigbare resultaat 
aangeslen onoplosbare substraat in die sisteem gebruik word om antiliggame van die IgG en IgM 
klas van die bg. virusse aan te dui. 
Die sensitiwiteit en spesifisiteit van die dot-ELISA vir elke virus is bepaal deur die serologiese 
resultate van die immunofluoressensie en hemagglulinasie-inhibisieloelse Ie vergelyk mel die van 
die dol-ELISA. 
Die sensiliwiteit en spesifisiteil van die dot-ELISA vir IgG bepalings van elke virus was 5005 volg: 
Slenkdalkoorsvirus, 100 % sensitiwileil en 87 % spesifisiteit; Wesnylvlrus, 100 % sensitiwileit en 
98 % speslfisitelt; Sindbisvlrus, 88 % sensitiwiteil en 86 % spesifisileil en Wesselsbronvlrus, 54 % 
sensitiwileil en 94 % spesifisiteit. 
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Resultate van die dot-ELISA en immunofluoressensietoets vir die bepaling van IgM klas antiliggame 
van bg. virusse het 'n u~stekende korrelasie getoon. In hierdie geval is die sens~iw~e~ en 
spesifis~eit as 100 % vir elke virus bepaal. 
Die eenvoudige prosedures, lae kostes en die lett dat IgG sowel as IgM klas antlliggame teen die 
verskillende arbovirusse bepaal kan word, maak die dot-ELISA 'n bruikbare toets vir vroeEl 
diagnose van arbovirusinfeksies, sowel as vir sero-epidemiologiese studies. 
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D1 J D2 FI ! F2 HI D1 J D2 J FI J F2 J HI DI ! D2 [FI F2 HI DIJD2J FI J F2-L III 
23 I Hospital - : - - : - - · , • I -: - I • 
24 Hospital - : - - , - - · , • I • ! • I • I -: -I -: 
25 Hospital - , 
-
- , 
- -
- , - I -' 
-1-1':'1' : • I • 
26 Hospital I - , - I - , - I - I · ' • I . ' • I • 
27 H 08 pita I - - , - - - : - - - · , • · ' • I • I - , - I - , - I • 
28 Hospital • • 
29 Hospital : - I - I · ' • I I • I • • I • • I • I 
. , • 
30 Hospital I -! -I - ! - I - I - , - I - , - I - I • • I · ' • I • I • • I • 
31 Hospital I • : • I • • I • I · , • I - , - I • I • • I · , • I • 
I 32 Hospital - : - - , - - · , • I - : - I • H , 
H 
- I - ! - I -I I 33 Hospital - : - - • - , • • • • I • , 
34 Hospital - , - - , - - · : • I - ' - I • 
35 Hospital . : • . , 
. 1 
'1 
· 1 
: 36 Hospital • . , • 
37 Hospital 
38 Hospital 
39 Valspan 
: 
40 Valspan · ' • · , • 
41 Hospital I - ' - I - , 
42 Valapan · , • I • • 
43 Valapan 
·1 
I - , 
44 Valspan . , 
D1 =dot-ELISA observer 1 D2=dot-ELISA observer 2 Fl =IF test observer F2=IF test observer 2 HI=Baemagglutination Inhibition 
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I RVF IgG PATIENT LOCATION SIN IgG WN IgG 1 WSL IgG 
Dl D2 Fl F2 HI 01 I D2 Fl I F2 I HI Dl I D2 I Fl I F2 I HI I Dl I D2 I Fl F2 --L HI 
" I " I • I ": " I . I . 45 Valspan · . • , + + , . 
46 Valspan I • • I • • I · . • 
47 Hospital 
· : • 
48 Valspan 
49 Valspan 
· : • I • • I I • • I • • I I " . " I " " I I · : • I · : • 
50 Valspan · : • 
51 Valspan · . • • • 
52 Valspan " " . " " . " " 
"1 1 " . 
53 I Preezfontein Noord · . • " : " · . • . . • I I • : • I • : • 
54 I Preezfonteln Noord " . " " : " " . " " : " I I 
· : • I • : • H 
H 
H 55 Hospital 
I .1 • • • • 56 Hospital · . • • • I " I I " . " I " : " I I " . " I · . • 
57 Hospital " . , 
58 Hospital 
59 Hospital · , • I • • 
60 Hospital • • · : • 
61 Hospital • • • • • • • · : • • • I • • I • 
62 Hospital · , • • • • • · . • • • • • : • I • : • I • 
63 Hospital " I " I " I " I " I " I · . • · . • • • + I + : • I • 
64 Hospital " . , 
65 Hospital " , 
66 Hospl tal " , 
Dl=dot-EUSA observer 1 D2=dot-EUSA observer 2 Fl =IF test observer 1 F2=IF test observer 2 HI=Haemagglutmalion Inhibition 
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I RVF IgG SIN IgG WN JgG I WSL IgG PATIENT I LOCATION 
01 I 02 I Fl~ F2 J HI 011 02 1 F1 F2 HI 01 02 Fl ~ F2 --l- HI--l- 01--l-02 --l-Fl -I- F2 --l- HI 
67 I Kareelaagte · : • I + ' • I - , - I - : - I · ' + I + : • 
68 I KareeJaagte · : • - : - I I - : - I - : - I I . : • I • : . 
69 I Kareelaagte - , 
- I I - : - I - ' - I I • : • I • : • , 
I Kareelaagte - , - - I I - ' - I - : - I I · ' • I • ' . 70 
71 I Karee l aagte · : • · , • I I - : - I - I I · ' • I • , . I I · ' • 
72 I Kareelaagte · ' ·1 . i ·r 1- : -1 -: - I I · , • I • , . I I · ' • 
73 I Kareelaagte · , + I + ; • I I - : - I -: - I I · : • I · ' • I I · , • 
74 I , Kareelaagte 
· : • · , • - , - - , - · , • I • : • I I - : - I -
75 I Kareelaagte - - . : • - , - · , • I • : • I I - , - I - , 
76 Kareelaagte · ' • · ' • - , - - , - · ' • I · , • 
H 
<: 77 Kareelaagte • • • • • • • ' . I · : • I . ' • 
78 Kareelaagte • 
• I • ' . 
79 K a r8 e I aag ta 
80 K a fa e I aag te - , - , - - , 
81 K a fe e I aag te - , 
82 Kareelaagte - , 
· ' • I + • 
, , 
- , - , 
, 
: 83 Kareelaagte · , • • • , I - , -
84 K a re e laag te - - I - , - I I - : - I - ' - I I · , • I · : • 
85 I K a ra e laag ta + : • · : • - , - - - - - , - I 1 - -J -, 
86 I Kareelaagte - - - : - - : - + , • · , • I I -' - I - , , , 
87 I Kareelaagte - , - - - : - - , - - , - - , - I I - , 
88 I Kareelaagte · , + I + : ·1 1 + : +1 - : 
Dl=dot ELISA observer 1 D2 dot ELISA observer 2 FI-IF test observer 1 F2 IF test observer 2 HI=Haemagglutination Inhibition 
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I RVF IgG SIN IgG WN IgG WSL IgG PATIENT LOCATION 
DI D2 Fl F2 HI Dl D2 Fl F2 HI DI~ D2 Fl F2 J HI I Dl I D2 I Fl I F2 1 HI 
89 Kareelaagte 
90 Kareelaagte 
91 Kareelaagte 
I 
· i 
: 1 
: I .1 
1 
- , 
1 .1 1 
i 
1 1 1 
·1 92 Kareelaagte i i • 
93 KareelaBgta · : 
- , 
94 Kareelaagte 
96 Kareelaagte I • • I ... , • I , - - , - , - , , - , 
96 Kareelaagte 
· ' • . : • - - - : -
, 
97 I Kareelaagte - , , 
I 
, 
98 Kareelaagte - - , - - - , - - , - - , - , - , 
<: I 
99 I Kareelaagt& - ' - - , - - , - - , - ... : ... . ' • 
100 Kareelaagte 
Dl=dol-ELISA observer 1 D2=dot-EUSA observer 2 Fl=IF test observer 1 F2=IF test observer 2 HI=Haemagglutination Inhibition 
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1.2. DOT-ELISA RESULTS 
RVF SIN WN WSL C 
1 
2 
3 
4 
5 
6 
7 
: I', . ~- : 
9 
10 
11 
C It 'J 
, t.w '"' 12 .., 
13 
14 ) 
17 
18 
19 ~ 
VI 
RVF SIN WN WSL C 
20 •..  
22 
C " r' ,,,' 
23 f 
'f";' ~---~- -.----
24 i -' " II:-,...,~ ,....,., -"-'--.-", - - -" 
25 I '" 
~--- -~J 
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27 
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~1 
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-J.'" 
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, , 
~-.-.. - - - ,~ , 
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l _ _ . 
I, ~ i _ .._ .. .1.._-+---'_ 
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33 
C ~' 
, 
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! .-. 
-.., ' ; ~V::'L j "::,.. i '1 
34 'J .• ) 
35 1::-
36 0 
37 r --.-------' 1 
t-- _.-
I ~~ " 
38 I 
L_ . 
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RVF SIN WN WSL C RVF SIN WN WSL C 
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39
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RVF SIN p, 
76) L-
771 " 0 
f~' c • 
0 
WN WSL C 
--- - ,.....-..,..--.-
• e 
• 
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• 
33 - - -.. --
. ___ --1 83 . J 
--l ~,-- -84, • 
• 0 I t;<- ~ J 85 • , iw 
86; J • -' ~" ; , - --- - --- .-
81 ,, - - - -' 
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99 
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100 
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1.3. IMMUNOFLUORESCENCE EXAMPLES 
RVF virus Infected Vero cells stained by the Indirect fluorescent antibody technique with positive RVF human serum and 
anti-human IgG conjugate, (Magnification x 200) 
SIN virus infected Vero cells stained by the Indirect fluorescent antibody technique with posijive SIN human serum and 
anti-human IgG conjugate, (Magnification x 200) 
IX 
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.-r- .... . .. ,.. .. ~ 
1 ., .'; I ,( ~"'" 
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).., . .. • 
• 
WN virus Infected Vero cells stained by the Indirect fluorescent antibody technique with positive WN human serum and 
anti·human IgG conjugate, (Magnification x 200) 
WSL virus Infected Vero celis stained by the Indirect fluoresoentantibody technique with positive WSL human serum and 
anti·human IgG conjugate, (Magnification x 200) 
x 
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1.4. STATISTICAL ANALYSIS OF SEROLOGICAL RESULTS 
RVF virus 
01 :F1; 01 :F2; 02:F1; 02:F2. 
IF TEST 
+ TOTAL 
dot- + 21 10 31 
ELISA 0 69 69 
TOTAL 21 79 100 
SENSITiViTY 100% 
SPECIFiCITY 87% 
KAPPA 0.7259 
ACCURACY 90% 
01 :HI; 02:HI. 
HI 
+ TOTAL 
dot- + 6 2 8 
ELISA 2 23 25 
TOTAL 8 25 33 
SENSITIVITY 75% 
SPECiFICITY 92% 
KAPPA 0.6731 
ACCURACY 88% 
WN virus 
01 :F1 ; 01 :F2 ; 02:F1 ; 02:F2. 
IF TEST 
+ TOTAL 
dot- + 47 1 48 
ELISA 0 52 52 
TOTAL 47 53 100 
SENSITIViTY 100% 
SPECIFiCITY 98% 
KAPPA 0.9605 
ACCURACY 99% 
XI 
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Dl :HI; D2:HI. 
HI 
+ TOTAL 
dot- + 19 2 21 
ELISA 1 11 12 
TOTAL 20 13 33 
SENSITIVITY 95% 
SPECIFICITY 85% 
KAPPA 0.8412 
ACCURACY 91% 
SIN virus 
Dl :Fl ; Dl :F2 ; D2:Fl ; D2:F2. 
IF TEST 
+ TOTAL 
dot- + 7 13 20 
ELISA 1 79 80 
TOTAL 8 92 100 
SENSITIVITY 88% 
SPECIFICITY 86% 
KAPPA 0.6022 
ACCURACY 86% 
Dl:HI; D2:HI 
HI 
+ TOTAL 
dot- + 10 1 11 
ELISA 3 19 22 
TOTAL 13 20 33 
SENSITIVITY 77% 
SPECIFICITY 95% 
KAPPA 0.7390 
ACCURACY 88% 
XII 
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Dl :HI; D2:HI. 
HI 
+ TOTAL 
dol- + 19 2 21 
ELISA 1 11 12 
TOTAL 20 13 33 
SENSITIVITY 95% 
SPECIFICITY 85% 
KAPPA 0.8412 
ACCURACY 91% 
SIN virus 
Dl :Fl ; Dl :F2 ; D2:Fl ; D2:F2. 
IF TEST 
+ TOTAL 
dOI- + 7 13 20 
ELISA 1 79 80 
TOTAL 8 92 100 
SENSITIVITY 88% 
SPECIFICITY 86% 
KAPPA 0.6022 
ACCURACY 86% 
Dl :HI; D2:HI 
HI 
+ TOTAL 
dol- + 10 1 11 
ELISA 3 19 22 
TOTAL 13 20 33 
SENSITIVITY 77% 
SPECIFICITY 95% 
KAPPA 0.7390 
ACCURACY 88% 
XII 
© Central University of Technology, Free State
WSLvirus 
D1 :F1 ; D2:F1 ; D1 :F2 ; D2:F2. 
IF TEST 
+ TOTAL 
dot- + 7 5 12 
ELISA 6 82 88 
TOTAL 13 87 100 
SENSITIVITY 54% 
SPECIFICITY 94% 
KAPPA 0.4900 
ACCURACY 89% 
D1 :HI; D2:HI. 
HI 
+ TOTAL 
dot- + 3 2 5 
ELISA 9 19 28 
TOTAL 12 21 33 
SENSITIVITY 25% 
SPECIFICITY 90% 
KAPPA 0.2303 
ACCURACY 67% 
XIII 
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I RVF IgM SIN IgM WN IgM WSL IgM !" ~ PATIENT LOCATION ... 
01 02 Fl F2 01 02 Fl F2 01 02 Fl F2 NIV 01 02 Fl F2 (J) ~ 
Petrus Steyn I - : - I - : - I - : - I - : - I - : - I - : - I - : - I - : - I m s: :II 
1 I 1 I 1 I - : ~ 1 1 1 
0 0 
2 Petrus Steyn 5 m 
-I , C) m 3 Petrus Steyn - : - ~ :II 
4 Petrus Steyn - , - I r- s: 
:II Z 
5 Petrus Steyn 
1 I 
- , 
1 I 1 I ~ 1 - i 1 1 
m :to (J) 
c: =! 
6 Petrus Steyn ~ 0 Z 
7 Petrus Steyn - : - I CJ) 
8 I Hospital I - , - I - : - I I - : - - , - . : • . , • , 
I 9 I Hospital I - : - I - : - I I - i - - , - . , • . ' • I + 
>< 
H 
I 10 I Hospital I -' - I - : - I I - : - - - - , - - , -
<: 1 1 Hospital - ' -, 
12 Hospital -
13 Hospital - , I - , - I - - I I - - , - - , . -
14 I Hospital • • . : • 
16 I Hospital 
16 Hospital 
17 Hospital , - , . - ' - , -
18 Hospital 
19 Hospital 
1 
- ' -1- 1 
1 1 i 1 1- : ~ 1 1 1 1 - : 20 Hospital i ~; - :-21 Hospital - , - , 
22 Hospital 
Dl=dot-EUSA observer 1 D2-dot'-EUSA observer 2 Fl =IF test observer 1 F2=IF test observer 2 NIV=National Institute for Virology 
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I I RVF 10M SIN 10M WN 10M I WSL 10M PATIENT LOCATION 
D1 J D2 F1 I F2 HI D1 I D2 F1 I F2 HI D1 I D2 I F1 I F2 I HI I D1 I D2 I F1 I F2-l H 
23 ! Hospital I - i - - I - - : - I -
24 I Hospital I -, - - , - - - -' - - , -
25 I Hospital - - : - 1 1 - ' -I - : 
26 Hospital - , - ' - , 
27 Hospital 
28 Hospital - , - - : - -
29 Hospital - - - I - - I - I - ; - I I - I - I - , -
30 Hospital 
31 Hospital :- 1- ; -1 1- -1-
>< 32 Hospital 
<: 
33 I Hospital 
34 -H-OS-p-lt-a-I-------1--~-~~-+~~~~-+--~I~+I--~--+1--~:-- +1-11-- r--41---+ 
35 Hospital -I - 1 1 1 -
36 Hospital - ; 
37 Hospital ' -
38 Hospital - 1 -,- 1 1 -
39 V.lapan -I : -I , 1 -
40 Valspan - I I - I - I -
41 Hosp i tal I -
42 Valapan 1 I < 1 I _ 1 _ _ 1 1-
43 Valspan 
44 Valspan [I - I -
Dl=dot-ELISA observer 1 D2-dot-ELISA observer 2 FI-IF test observer 1 F2=IF test observer 2 HI=Baemagglutination Inhibition 
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I RVF IgM PATIENT LOCATION SIN IgM WN IgM WSL IgM 
Dl I D2 FJ I F2 HI Dl I D2 Fl F2 HI 01 02 Fl F2 HI 01 02 Fl F2~ HI 
45 Valspan I -: - - . - - : - - . - - : -. 
Valspan I - : - - : - - . - - . - - . - - : -46 
47 Hospital 
-I I . : • I • : • , 
48 Valspan I I 
- . 
49 Valspan - . -
60 Valspan 
51 I Valapan - : - - . - - . - - . - -
. 
52 I - . - - . - - : - - . - - . Valspan 
53 Preezfonteln Noord - : - • .. . : • : I I 
I 54 Pr98zfontein Noord - - . - - - - . - I I - : ->< . <: I H 55 Hospital 
I I t t I 
56 I Hospital - - . - - : - - . - I I - . - I - . - I I - . -
· 
57 Hospital - . - - : - -
. : I I I I I 
58 Hospital - . - - . - - . - - . - I I - . - I - . - I I -: -
59 Hospital 
· 
I Hospital - . - -60 I I 
61 I Hospital - : - - . - I I - , - I - . - I I - . - I - , - I I - . - I -
62 I Hospital -
· 
- - . - - . -
. 
- : - -63 I Hospital - . -
64 I Hospital - - . - - : - - . - - : - -
65 I Hospital - . - - : - - . - - . - - . - - . - - . -
. 
I - . -66 Hospital - . - - I _ I _ • _ I • - • - I _ I _ I . - -
Dl =dot-ELISA observer 1 D2-dot ELISA observer 2 F1-IF test observer 1 F2=IF test observer 2 HI=Haemagglutination Inhibition 
© Central University of Technology, Free State
I RVF IgM SIN IgM WN IgM WSL IgM PATIENT I LOCATION 
D1 I D2 F1 I F2 HI D1 ! D2 FI I F2 HI D1 I D2 F1 F2 HI D1 D2 F1 F21 HI 
67 I Kareelaagte - ' - - - , - - ' - - : - - , - - , - -
: : 
68 I Kareelaagte - - - - - : - - : - - , - - , - -, 
69 I Kareelaagte - - , - - : - - , - - , - - : - - -
I Kareelaagte - - , - - , - -70 - , - - ' - - , - - , -
71 I KareeJaagte - , - - : - - - , - I I -: - , - - , . - , -
72 I Kareelaagte - - - : - - ' - I I - : - , - - , • - ' - , - , -, 
73 I Kareelaagte - : - - ' - - , 
74 I Kareelaagte 
75 Kareelaagte - , - - - , - - : - - - , - - : - - , 
>< 76 Kareelaagte - , - - , - - - - ' - - , - - - - ' - - , -<: I--[:T -: H Kareelaagte - - : - - - , - - : - - -H 77 , : 
78 Kareelaagte I -: - I - : - I I - , - I - , - I I - : - I - ' - I I - : - I - : -
79 Kareelaagte 
I 
- , 
- - ' - -
- , 
- - ' -
- , 
- I I -
, 
80 I Kareelaagte , 
81 I Kareelaagte - : - - : - - - , - - : - -, , 
82 I Kareelaagte - : - - - , - - : - - , -
83 I Kareelaagte - , - - - - - ' - -
- -
t-
- : - - , - I I • : • I . : • 84 I Kareelaagte 
85 I Kareelaagte - - , - - : -
86 I Kareelaagte - , - - , - - , - I - I 
87 I Kareelaagte - , - - - - , - I - : - I I - ' - I - ' - I I - : -
88 I Kareelaagte - , - - , - I I - ' - I - ' - I I - , - I - : - I I - , - I - , -
Dl=dot-EUSA observer 1 D2- dot-EUSA observer 2 Fl =IF test observer 1 F2=IF test observer 2 HI=Haemagglutination Inhibition 
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I RVF IgM SIN IgM WN 10M WSL IgM PATIENT LOCATION 
01 I 02 I F1 I F2 I HI 01 02 F1 F2 HI 01 02 F1 F2 HI 01 02 - Fi F2 HI 
I 
-
- I - : - I - '- I - ' - I - : - 1- : - I - ' - I - , -89 Kare e I aag ta 
90 KareeJaagte -
91 Kareelaagte 
92 Kareelaagte 
I 
- ' 
I I I , 93 Kareelaagte 
94 Kareelaagte 
95 Kareelaagte 
96 Kareelaagte 
97 Kareelaagte 
>< , 
-
- , 
<: 98 Kareelaagte 
H 
H 99 Kareelaagte H 
100 Kareelaagte ' -
Dl =dol-ELISA observer 1 D2=doLEUSA observer 2 Fl =IF test observer 1 F2=IF lest observer 2 HI=HaemagglutloatioD Inhibition 
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2.2. DOT-EUSA RESULTS 
XIX 
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2.3. STATISTICAL ANALYSIS OF SEROLOGICAL RESULTS 
RVF virus 
01 :F1; 01 :F2; 02:F1; D2:F2. 
IF TEST 
+ TOTAL 
dot- + 1 0 1 
ELISA 0 99 99 
TOTAL 1 99 100 
SENSITIVITY 100% 
SPECIFICITY 100% 
KAPPA >0.75 
ACCURACY 100% 
WNvirus 
01 :F1; 01 :F2; 02:F1; 02:F2. 
IF TEST 
+ TOTAL 
dot- + 4 0 4 
ELISA 0 96 96 
TOTAL 4 96 100 
SENSITIVITY 100% 
SPECIFICITY 100% 
KAPPA >0.75 
ACCURACY 100% 
SIN virus 
01 :F1; 01 :F2; 02:F1; 02:F2. 
IF TEST 
+ TOTAL 
dot- + 1 0 1 
ELISA 0 99 99 
TOTAL 99 100 
SENSITIVITY 100% 
SPECIFICITY 100% 
KAPPA >0.75 
ACCURACY 100% 
XXII 
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WSLvirus 
01 :F1; 01 :F2; 02:F1; 02:F2. 
dot-
ELISA 
SENSITIVITY 
SPECIFICITY 
KAPPA 
ACCURACY 
+ 
TOTAL 
'Mathematical manipulation 
+ 
0.05' 
o 
0.05 
100% 
100% 
>0.75 
100% 
IF TEST 
o 
100 
100 
XXIII 
TOTAL 
0.05 
100 
100.05 
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